Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 847.1;Proximal tubular cells: 525.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019881, HPA057134"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cell Junctions"		"HPA019881: AB_1857978, HPA057134: "	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	6.3	6.1	7.2	4.8	7.5	3.4	3.8	7.9	7.3	3.4	6.0	9.1	6.5	3.1	3.7	3.4	3.6	4.9	12.0	6.6	7.8	19.2	30.6	4.6	5.2	7.2	7.8	3.9	6.6	7.2	5.1	3.0	7.4	6.5	7.4	9.6	5.0	3.3	12.2	5.5	6.1	3.1	7.1	4.8	5.5	7.0	8.2	5.1	5.7	10.3	3.4	3.5	3.1	7.4	5.9	7.6	7.6	13.6	10.5	13.1	4.2	4.8	5.8	3.5	5.4	10.1	7.5	11.1	16.2	5.5	18.4	6.4	6.7	9.7	5.4	17.4	6.2	10.4	7.7	7.0	5.3	6.7	4.6	7.6	9.4	4.7	9.0	8.5	8.3	11.3	17.0	5.7	7.0	6.1	12.1	12.9	5.1	11.7	5.9	10.4	6.6	14.0	11.7	5.4	15.0	5.2	5.7	19.1	14.1	8.8	13.2	5.5	9.7	6.2	3.5	1.7	4.6	10.7	29.3	11.1	6.5	23.8	19.1	4.8	5.3	3.6	4.4	5.7	6.1	6.9	4.9	5.0	4.7	4.9	5.7	5.1	6.2	4.6	5.8	3.7	5.3	4.8	7.2	7.5	7.9	7.3	6.6	7.8	7.2	7.8	7.4	7.1	8.2	7.4	27.9	67.3	41.7	19.6	19.7	17.2	26.6	66.4	18.8	18.7	29.4	32.3	94.6	45.8	46.9	31.3	16.7	56.8	22.6	88.4	158.5	43.2	847.1	34.0	31.3	24.0	54.7	37.2	12.1	40.2	31.1	26.2	23.9	31.8	14.5	30.3	21.4	215.5	86.7	5.0	14.3	85.8	67.1	24.5	23.7	131.5	19.6	35.0	26.6	14.0	68.9	41.7	18.6	15.6	18.7	29.2	130.7	24.0	25.4	23.2	47.1	525.2	56.8	31.8	26.3	50.6	64.2	117.1	27.3	19.5	23.4	40.0	20.5	43.4	69.4	28.6
ADAM22	MDC2	ENSG00000008277	"ADAM metallopeptidase domain 22"	Q9P0K1	7	87934143-88202889	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 77.2"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 286.7;Inhibitory neurons: 304.9;Oligodendrocyte precursor cells: 184.0;Oligodendrocytes: 125.6"	"Cancer enhanced"	"Detected in many"		"glioma: 4.0"	"Region enhanced"	"Detected in all"		"cerebellum: 77.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 81.8;SH-SY5Y: 76.9;U-266/84: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050325, CAB079064"		Supported	Approved	"Cell Junctions"	"Intracellular and membrane"	NA	NA		180000	"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"		"CAB079064: , HPA050325: AB_2681087"	"unprognostic (1.20e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.61e-4)"	"unprognostic (4.70e-2)"	2.0	9.1	7.2	0.9	9.2	0.9	1.3	77.2	30.6	6.0	0.0	1.5	0.6	4.6	8.5	0.8	2.4	2.5	2.1	12.2	8.9	3.8	0.2	1.2	2.2	14.4	5.6	3.9	1.0	2.1	3.4	0.3	14.7	11.0	1.4	10.3	0.7	5.1	2.5	1.0	1.1	3.5	2.7	2.0	0.6	1.9	13.8	2.5	3.2	1.2	1.1	1.6	2.6	12.3	2.5	0.7	4.8	5.8	1.4	0.3	3.5	0.1	0.5	0.4	0.5	5.1	8.3	7.4	2.0	0.0	3.5	0.2	7.0	0.1	0.1	20.5	9.0	5.6	5.4	1.5	0.1	6.9	0.1	0.7	0.0	0.1	0.3	6.3	0.5	8.1	0.2	81.8	0.2	6.7	8.9	1.4	11.6	0.6	2.6	5.2	18.8	10.7	0.1	4.1	25.9	76.9	4.1	0.1	0.8	3.7	3.5	0.8	0.1	4.8	3.3	0.9	3.6	18.8	33.2	5.9	4.1	14.2	7.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	7.2	9.2	77.2	30.6	12.2	8.9	14.4	5.6	14.7	2.7	13.8	12.3	2.4	0.0	2.0	45.7	1.1	0.5	1.7	0.0	2.8	28.4	0.5	0.6	3.1	0.0	0.6	1.8	22.9	0.4	1.9	0.3	1.9	0.0	7.8	2.2	6.9	1.5	1.2	1.3	286.7	0.0	0.1	4.8	1.1	3.3	0.0	0.7	0.7	0.0	0.1	15.2	304.9	0.6	0.0	0.3	0.6	1.5	2.5	0.2	1.8	18.7	0.0	1.4	2.1	184.0	125.6	0.0	3.1	2.6	0.9	0.4	0.3	1.0	0.8	10.9	0.0	2.9	3.2	0.8	1.9	0.4	0.4	0.0	2.2	3.7	1.3	0.3
AMOTL2	LCCP	ENSG00000114019	"Angiomotin like 2"	Q9Y2J4	3	134355347-134375479	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 89.2;Suprabasal keratinocytes: 130.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 259.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063027			Approved	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA063027: AB_2684924"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.01e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.17e-2)"	80.0	11.1	24.1	7.1	42.5	0.2	55.9	26.0	32.7	34.4	32.0	28.3	7.7	44.3	9.1	37.1	37.5	22.8	25.9	17.5	22.9	25.6	17.2	33.4	11.9	40.8	35.0	21.5	27.2	9.6	5.7	33.6	33.6	24.6	5.5	5.4	25.1	15.8	16.8	39.7	15.8	16.7	21.6	20.5	23.1	4.2	36.3	4.3	29.5	15.9	7.2	29.1	33.3	70.2	99.1	43.1	29.6	30.9	30.3	37.3	259.9	97.5	54.8	87.6	43.0	132.5	30.3	0.0	119.9	69.4	50.0	72.2	19.4	26.3	39.9	0.2	2.2	0.2	22.7	14.4	56.8	0.2	0.2	53.7	79.5	34.5	39.7	35.1	42.3	0.9	0.7	0.2	59.2	31.7	0.3	0.3	37.9	21.4	16.3	0.2	37.4	0.3	56.4	22.7	4.5	11.7	73.8	94.3	68.8	66.8	88.2	0.8	72.4	59.5	53.2	41.7	59.7	0.1	0.3	0.4	22.1	0.1	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	42.5	26.0	32.7	17.5	22.9	40.8	35.0	33.6	21.6	36.3	70.2	24.0	60.9	17.3	2.6	0.2	72.9	18.4	15.4	30.1	10.4	29.2	21.5	15.6	52.9	16.4	18.4	18.8	30.4	1.1	6.5	17.6	27.5	4.0	59.7	29.1	30.1	12.5	0.0	4.5	13.1	29.9	30.3	20.4	89.2	1.3	34.1	51.8	25.8	3.0	1.7	5.8	3.6	6.1	1.6	7.8	10.9	35.8	1.7	14.2	9.4	0.0	12.1	0.0	18.6	56.9	52.8	4.2	19.9	0.0	30.0	10.6	19.3	16.2	5.1	13.1	12.1	46.1	0.2	0.6	25.3	130.1	24.8	2.6	8.7	4.5	37.3
AOPEP	"AP-O, APO, C90RF3, C9orf3, FLJ14675"	ENSG00000148120	"Aminopeptidase O (putative)"	Q8N6M6	9	94726604-95087159	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 148.2;Cytotrophoblasts: 65.9;Extravillous trophoblasts: 43.7;Syncytiotrophoblasts: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: AB_2686553"	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	5.6	6.6	11.8	4.9	20.4	2.2	7.0	16.9	16.3	8.1	23.8	6.9	4.3	18.5	8.3	16.9	10.3	12.1	29.4	15.9	15.5	7.2	7.6	10.4	2.2	23.0	15.7	8.1	11.2	16.3	5.7	24.3	20.7	14.3	5.8	4.7	12.2	15.2	30.5	38.6	5.0	15.8	11.1	5.0	5.7	6.0	15.4	2.6	11.2	15.3	5.6	7.7	6.8	40.5	6.8	27.6	3.3	5.3	3.4	3.8	12.4	6.4	3.0	6.3	4.1	6.3	8.7	2.1	5.3	9.8	8.7	24.8	5.7	6.1	3.4	13.2	4.9	2.0	30.1	5.8	6.1	1.8	1.4	4.4	23.7	5.5	4.1	17.7	3.5	3.3	3.4	3.0	11.4	10.1	2.8	2.3	4.4	7.8	10.7	4.2	9.4	2.7	11.0	6.4	6.6	9.7	11.2	9.4	2.5	8.5	10.8	1.5	2.7	2.9	2.8	10.8	3.4	2.5	3.6	1.0	9.8	1.7	4.8	0.0	1.4	0.9	1.4	1.0	0.8	0.9	1.1	1.2	2.2	2.2	0.8	1.0	0.5	1.4	0.7	2.1	0.8	0.7	11.8	20.4	16.9	16.3	15.9	15.5	23.0	15.7	20.7	11.1	15.4	40.5	20.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.2	0.0	0.0	0.0	0.0	65.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	43.7	13.8	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	88.2	0.2	0.0	0.0	0.0
ARHGAP28	"FLJ10312, KIAA1314"	ENSG00000088756	"Rho GTPase activating protein 28"	Q9P2N2	18	6729716-6915716	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 25.9;testis: 77.5"	"Group enriched"	"Detected in many"	14	"Early spermatids: 536.8;Late spermatids: 488.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"AF22: 30.4;CACO-2: 32.8;SuSa: 22.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030413, HPA030414, HPA030415"	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions"		"HPA030413: AB_10601455, HPA030414: AB_10670042, HPA030415: AB_10669598"	"unprognostic (8.33e-2)"	"unprognostic (8.79e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.94e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.56e-3)"	"unprognostic (9.52e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.59e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.76e-2)"	4.7	1.9	1.1	1.7	1.2	0.8	2.7	1.7	1.6	8.6	0.8	1.9	1.7	2.9	8.7	1.9	3.1	6.6	2.0	1.5	1.6	8.4	0.9	4.6	1.7	0.4	0.2	10.4	3.8	3.0	0.8	25.9	0.5	3.9	2.3	1.4	0.8	2.2	4.9	2.1	1.8	1.4	0.1	12.6	2.1	77.5	1.1	3.8	2.9	1.6	0.9	5.4	3.0	0.8	0.2	0.2	30.4	3.1	6.3	10.5	4.9	2.2	5.1	2.5	5.3	32.8	0.2	0.2	1.0	0.4	1.7	1.4	0.1	0.8	3.7	1.0	1.8	0.1	2.9	0.2	1.1	0.1	0.1	12.6	0.6	2.7	0.2	0.3	7.8	0.5	0.8	2.5	4.1	0.5	0.5	0.3	9.6	0.4	1.4	0.1	2.7	0.2	0.0	2.9	2.9	11.9	0.1	2.8	0.5	22.6	0.2	0.1	1.3	0.5	13.1	10.1	0.4	0.2	0.1	0.1	5.0	0.3	1.1	0.7	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	3.0	0.1	0.0	0.2	0.0	0.0	1.1	1.2	1.7	1.6	1.5	1.6	0.4	0.2	0.5	0.1	1.1	0.8	8.3	0.0	1.9	6.2	0.1	1.9	1.3	0.2	0.0	1.5	0.9	0.5	1.8	0.0	0.7	1.8	20.9	14.9	0.0	0.0	0.0	1.1	536.8	0.5	14.6	7.9	0.0	0.0	7.1	2.7	2.7	16.1	0.0	0.4	0.0	25.8	4.2	0.2	2.1	0.0	34.4	0.1	0.0	0.3	0.4	488.0	18.3	0.5	0.0	12.2	0.0	0.2	0.0	24.6	3.6	0.7	0.0	14.3	0.1	4.7	0.0	3.8	0.0	0.8	0.0	11.0	5.4	14.3	3.7	0.8	1.4	6.6	0.3	23.7	0.0	1.3
C11orf52	"FLJ25219, MGC14839"	ENSG00000149300	"Chromosome 11 open reading frame 52"	Q96A22	11	111918032-111926871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.8;Breast glandular cells: 3.3;Cholangiocytes: 2.8;Endometrial ciliated cells: 3.1;Gastric mucus-secreting cells: 4.1;Respiratory ciliated cells: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;CAPAN-2: 23.5;Hep G2: 18.2;MCF7: 17.6;RPTEC TERT1: 27.1;SK-BR-3: 22.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038387, HPA038388"	Uncertain		Enhanced	"Cell Junctions"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions"		"HPA038387: AB_10670167, HPA038388: AB_2675987"	"unprognostic (1.30e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.84e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.57e-1)"	"unprognostic (8.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.44e-1)"		"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	3.3	0.7	1.0	0.4	0.9	0.0	25.9	4.1	1.3	3.8	2.2	5.2	10.4	2.3	23.7	6.4	17.7	12.3	3.2	0.9	0.9	43.9	22.8	9.7	0.1	1.1	1.0	1.5	25.8	30.8	16.4	10.1	1.7	15.4	6.2	0.1	26.8	10.2	9.3	9.7	9.2	0.8	1.1	0.9	20.9	1.0	1.1	1.0	20.1	8.3	1.3	4.6	3.2	1.5	4.3	0.0	0.0	0.0	2.9	0.4	17.7	1.0	0.8	0.1	0.0	6.8	23.5	0.0	10.6	2.3	0.0	5.4	0.0	1.4	0.1	0.0	0.7	0.0	0.5	18.2	0.0	0.0	0.0	0.3	5.2	0.0	0.2	0.2	1.0	0.0	0.0	0.0	1.5	17.6	0.0	0.2	0.1	12.5	1.8	0.0	1.5	0.0	27.1	15.6	1.2	0.0	0.0	22.9	0.0	2.4	76.5	1.6	2.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	4.1	1.3	0.9	0.9	1.1	1.0	1.7	1.1	1.1	1.5	0.0	6.4	2.8	0.0	0.0	0.1	1.6	0.2	1.2	0.0	3.3	0.9	0.6	2.8	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.3	0.0	3.1	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.5	4.1	1.9	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	1.9	1.3	6.7	0.0	0.0	0.3	0.3	0.1	0.1	0.6	0.3	1.4	0.0	0.2	0.2	0.7
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453925-37623495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.4;Distal enterocytes: 61.3;Exocrine glandular cells: 51.8;Oligodendrocyte precursor cells: 46.8;Pancreatic endocrine cells: 53.6;Paneth cells: 67.2;Proximal enterocytes: 52.3;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.6"	"Group enriched"	"Detected in some"	5	"OE19: 64.6;RT4: 81.0;SK-BR-3: 32.6;T-47d: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA043458: AB_10960696, HPA052894: AB_2681982"	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	3.4	0.3	2.7	3.0	2.9	3.8	3.8	5.3	4.3	10.2	5.9	25.5	17.7	6.7	0.2	2.1	2.8	9.2	0.4	3.5	4.2	12.4	36.0	3.7	0.5	4.9	4.9	0.2	24.9	16.0	1.2	7.6	4.2	1.7	23.7	4.6	28.2	6.8	0.2	1.6	19.6	4.0	4.5	0.3	20.7	1.4	4.9	0.2	1.5	0.4	4.3	8.8	2.9	4.1	0.1	0.2	3.2	0.3	0.0	0.0	4.2	0.7	0.0	0.0	0.0	12.6	5.2	0.1	3.0	0.0	0.1	0.4	0.2	0.8	0.1	0.0	0.4	0.0	8.3	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	14.3	0.2	0.2	0.5	64.6	1.7	0.1	7.8	0.2	12.7	81.0	0.9	0.3	0.5	32.6	1.0	4.0	113.1	0.7	0.6	0.4	4.5	0.2	1.6	0.2	0.1	0.5	0.0	6.9	5.6	0.9	1.4	2.1	0.6	0.2	0.4	0.2	0.3	0.4	0.2	0.5	0.5	0.8	8.6	0.8	0.1	1.6	0.7	0.3	2.7	2.9	5.3	4.3	3.5	4.2	4.9	4.9	4.2	4.5	4.9	4.1	0.3	0.0	12.6	45.4	0.7	0.3	7.8	4.9	0.0	0.6	7.1	3.9	0.2	27.1	10.1	11.0	0.0	6.7	0.2	61.3	11.7	25.2	1.2	9.5	0.4	0.9	9.6	0.0	2.3	51.8	4.7	0.3	33.6	5.5	0.0	0.0	0.0	13.1	0.7	0.0	2.4	28.0	4.1	0.0	0.3	2.4	0.0	0.2	3.6	22.5	0.6	5.3	0.0	46.8	1.8	53.6	67.2	0.0	0.0	7.8	52.3	9.2	12.3	1.0	0.0	0.2	0.9	0.3	0.2	0.5	0.0	47.5	0.4	0.1	31.8	19.1
CADM1	"BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1"	ENSG00000182985	"Cell adhesion molecule 1"	Q9BY67	11	115169218-115504957	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 287.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 464.8;Astrocytes: 980.7;Bipolar cells: 566.6;Muller glia cells: 489.9;Oligodendrocyte precursor cells: 676.5;Oligodendrocytes: 622.8;Rod photoreceptor cells: 759.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.0;myeloid DC: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.1;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 294.7;WM-115: 187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037266	Enhanced		Supported	"Cell Junctions"		NA	NA		220000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"		"CAB037266: AB_532287"	"unprognostic (1.50e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (4.11e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.40e-2)"	7.1	29.9	46.9	6.1	59.2	0.4	17.0	78.7	53.0	21.3	6.1	11.7	7.8	17.4	103.7	12.6	22.6	12.1	25.7	47.6	57.4	29.1	65.3	72.0	14.1	41.1	40.1	12.3	16.0	56.6	26.0	37.9	44.6	15.2	8.1	287.7	38.0	28.0	7.2	10.9	8.8	8.6	30.3	8.0	12.5	50.5	55.8	8.6	69.7	8.1	14.6	13.1	4.8	38.0	0.4	23.3	25.6	0.1	0.0	0.0	0.1	24.1	41.1	3.1	0.3	294.7	26.1	0.0	75.9	36.5	25.2	4.8	4.8	27.4	2.0	1.0	38.3	0.0	7.8	114.5	0.3	0.1	56.5	0.0	38.6	0.0	63.8	16.5	1.1	17.3	0.0	2.7	4.3	19.3	20.0	0.6	24.0	0.3	0.0	0.1	0.4	61.6	44.8	0.9	50.2	107.1	0.0	25.4	21.7	102.4	92.4	1.3	0.0	2.3	44.9	23.3	13.0	64.9	98.9	18.7	36.3	0.2	187.5	0.2	0.0	0.0	8.0	0.0	3.4	1.5	2.9	2.1	8.1	0.3	0.1	1.8	0.0	0.5	0.1	0.0	4.7	1.9	46.9	59.2	78.7	53.0	47.6	57.4	41.1	40.1	44.6	30.3	55.8	38.0	14.0	464.8	195.3	980.7	6.5	20.6	26.7	2.8	19.4	566.6	22.1	22.5	61.7	34.3	27.5	36.8	350.3	71.6	6.8	1.5	11.7	39.2	189.1	88.5	6.0	10.6	7.8	5.3	301.7	2.0	5.0	13.2	3.6	126.9	24.1	36.8	2.9	45.9	36.8	30.3	310.9	2.1	4.1	8.5	20.9	224.0	5.9	14.2	44.4	60.0	13.3	489.9	2.1	676.5	622.8	9.3	0.5	4.1	88.9	38.5	0.3	8.2	8.7	759.5	0.0	13.3	11.7	55.2	23.0	9.2	23.4	32.2	8.1	5.2	4.3	13.5
CDC42SE1	"SCIP1, SPEC1"	ENSG00000197622	"CDC42 small effector 1"	Q9NRR8	1	151050971-151070325	"Predicted intracellular proteins"	"Cell shape, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 320.7;NK-cells: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 453.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027634	Approved		Supported	"Cell Junctions"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Cell Junctions"		"HPA027634: AB_10600861"	"unprognostic (1.59e-2)"	"unprognostic (5.76e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (9.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.86e-3)"	"unprognostic (4.12e-2)"	54.4	48.0	39.2	63.8	40.7	81.6	41.9	41.0	48.7	46.0	38.1	40.2	20.0	35.0	26.8	97.4	44.0	37.2	44.8	38.8	40.5	59.2	30.0	73.2	84.3	43.1	42.2	44.0	36.5	71.5	37.2	48.6	43.7	56.1	33.7	20.6	54.1	33.2	21.9	61.6	58.7	37.3	42.9	122.3	44.6	11.1	43.2	56.4	46.0	19.2	84.5	65.7	64.1	44.1	61.5	28.5	48.4	30.5	37.0	35.5	73.9	45.6	47.1	51.1	43.5	27.6	64.3	44.2	36.2	51.3	27.4	74.9	51.6	79.8	44.6	69.9	27.7	71.6	30.2	13.6	49.1	64.1	110.0	39.8	125.7	64.3	49.6	71.8	64.6	43.9	114.1	100.8	58.2	91.3	46.8	46.1	54.5	56.2	30.5	41.1	40.8	49.6	64.5	97.2	20.7	49.3	39.4	83.6	82.8	75.9	93.1	113.1	61.7	49.5	36.6	38.5	84.2	65.6	56.1	453.9	35.8	47.8	111.8	124.6	43.9	228.5	88.5	80.7	70.0	44.0	75.5	81.0	58.3	44.9	62.9	78.4	369.7	91.1	82.7	21.9	123.2	38.1	39.2	40.7	41.0	48.7	38.8	40.5	43.1	42.2	43.7	42.9	43.2	44.1	76.4	38.5	56.2	22.2	110.5	66.2	54.4	41.0	42.1	28.3	94.1	64.1	8.1	27.1	44.8	55.2	25.0	57.9	320.7	36.1	21.5	41.3	85.0	23.4	38.0	50.5	35.3	24.4	30.5	37.0	72.1	40.0	33.1	35.1	71.7	19.0	65.0	33.9	73.2	26.9	29.1	29.9	50.8	138.8	204.1	16.6	11.5	115.0	55.2	32.8	159.8	23.0	233.8	36.7	44.9	66.7	39.3	24.0	93.8	41.9	19.4	27.5	21.8	24.2	32.9	47.9	46.5	35.0	18.7	59.6	93.6	114.8	142.7	22.2	21.4	73.4
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"lung: 252.2;stomach 1: 724.9"	"Group enriched"	"Detected in some"	53	"Alveolar cells type 1: 1602.5;Alveolar cells type 2: 431.2;Gastric mucus-secreting cells: 1153.4;Pancreatic endocrine cells: 442.5"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.6;stomach cancer: 186.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"OE19: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"		"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.3	0.3	0.3	0.4	0.4	0.1	0.2	1.0	0.5	0.4	2.2	0.7	1.5	0.2	0.5	0.6	0.5	3.3	9.7	0.3	0.2	0.2	0.1	252.2	0.0	0.9	0.9	0.5	0.8	0.0	0.5	0.3	0.5	0.2	0.2	0.7	0.3	0.4	0.1	1.1	0.8	0.1	0.7	0.5	724.9	1.3	0.5	0.1	0.1	0.0	0.7	0.2	0.3	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.5	15.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.5	0.3	0.2	0.9	0.9	0.5	0.7	0.5	0.2	0.0	1602.5	431.2	1.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	17.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.3	0.2	0.6	0.0	0.0	0.5	11.4	0.0	1.4	1153.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	2.0	0.0	1.9	0.0	0.1	0.0	0.0	0.2	442.5	0.0	0.0	1.3	0.0	0.0	0.1	0.7	1.3	0.0	0.9	0.1	15.3	11.9	0.0	0.0	0.0	1.3	0.0	0.0	0.1
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.1;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 529.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 9.7"	HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.7	0.2	0.2	7.8	0.3	0.2	26.7	4.2	0.3	12.3	37.6	263.1	54.4	7.5	1.4	1.3	29.6	2.2	0.1	1.1	1.2	46.5	40.4	10.7	0.2	1.3	1.9	0.5	96.6	1.5	27.7	1.0	0.6	58.3	17.5	0.4	72.9	8.3	0.1	9.6	169.5	0.8	0.5	0.2	1.4	0.7	0.9	1.0	116.3	0.0	1.2	1.5	0.2	0.2	2.5	3.6	0.0	0.4	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	35.7	0.0	9.9	0.0	0.0	1.0	0.4	0.0	0.0	0.1	4.9	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	230.7	0.4	1.2	2.1	9.1	47.6	0.1	0.0	40.5	2.1	0.2	58.0	0.7	0.0	33.6	0.0	0.2	105.4	0.0	0.2	0.2	0.6	0.9	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.3	1.1	1.2	1.3	1.9	0.6	0.5	0.9	0.2	1.6	38.5	37.8	0.0	13.2	0.1	60.3	43.7	0.0	0.7	289.9	182.5	0.6	287.4	86.3	126.9	4.2	63.9	5.1	1839.9	9.8	297.5	0.0	1221.7	130.5	10.3	606.1	5.3	0.0	19.1	17.7	4.1	16.8	1555.7	28.0	1.5	0.4	40.5	5.1	0.0	0.0	1471.3	116.0	0.3	0.0	0.3	2.5	9.9	10.6	0.0	2.0	11.8	0.0	0.0	0.0	36.7	2326.0	0.0	4.4	433.2	3162.1	58.6	498.4	10.6	0.0	0.0	20.3	0.1	0.3	2.7	0.0	72.4	17.5	0.0	1266.0	607.3
COBLL1	KIAA0977	ENSG00000082438	"Cordon-bleu WH2 repeat protein like 1"	Q53SF7	2	164653624-164843679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 218.8;Cone photoreceptor cells: 250.2;Microglial cells: 351.3;Syncytiotrophoblasts: 331.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 15.0;naive B-cell: 9.4;plasmacytoid DC: 8.1"	"Group enriched"	"Detected in many"	13	"B-cells: 15.0;dendritic cells: 8.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 62.6;RPTEC TERT1: 63.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044933, HPA053344"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Cell Junctions"		"HPA044933: AB_2679148, HPA053344: AB_2682123"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.27e-13)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-1)"	35.1	51.4	9.5	7.4	8.5	4.1	13.8	6.4	9.2	10.1	28.7	8.0	10.7	4.6	15.6	32.6	4.8	12.3	7.2	6.6	7.1	68.8	107.6	18.2	12.8	8.9	7.9	12.5	43.7	10.9	5.0	50.9	9.4	27.4	7.8	56.8	17.9	28.0	3.3	16.9	7.8	7.4	6.8	9.9	30.0	2.0	12.8	4.8	18.4	7.2	16.2	22.6	16.4	6.3	10.7	2.2	5.9	0.0	7.1	1.3	11.9	34.0	13.3	4.7	5.6	8.9	4.3	1.0	6.9	3.2	5.0	38.4	26.2	21.3	5.6	2.9	10.7	10.5	9.5	36.3	10.2	0.0	0.0	1.8	19.8	1.0	27.6	5.8	21.1	1.3	0.0	62.6	7.5	12.5	0.3	0.1	2.9	25.9	12.8	1.3	22.4	10.4	63.1	36.0	14.4	5.8	16.1	14.7	4.6	11.4	10.7	0.0	9.5	11.3	9.7	3.8	8.3	24.3	10.0	3.6	4.7	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.8	0.0	8.1	0.0	0.4	9.5	8.5	6.4	9.2	6.6	7.1	8.9	7.9	9.4	6.8	12.8	6.3	56.4	70.5	66.5	7.5	102.5	97.3	54.3	14.5	30.7	21.6	22.4	22.4	9.3	30.0	26.0	218.8	250.2	52.1	40.8	11.3	62.6	25.5	0.1	24.6	12.2	47.1	22.2	22.5	23.7	33.8	71.3	35.0	53.5	19.5	34.1	9.0	6.1	127.9	8.7	3.3	30.9	11.0	24.4	3.9	9.0	1.3	14.6	3.7	19.6	351.3	0.7	144.5	0.0	5.0	1.6	29.8	4.9	7.9	154.8	46.0	12.6	28.6	12.4	190.2	46.0	8.6	71.2	0.6	2.7	69.0	70.3	331.4	8.3	8.0	10.0	75.6
CRB3	MGC17303	ENSG00000130545	"Crumbs cell polarity complex component 3"	Q9BUF7	19	6463777-6467221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 54.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 160.9;Pancreatic endocrine cells: 149.9;Paneth cells: 177.3;Suprabasal keratinocytes: 139.5;Urothelial cells: 243.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 9.2"	"Group enriched"	"Detected in many"	20	"B-cells: 3.1;T-cells: 9.2"	"Cell line enhanced"	"Detected in some"		"A-431: 57.9;BEWO: 35.1;CACO-2: 38.1;HaCaT: 36.9;hTCEpi: 27.8;OE19: 33.1;SK-BR-3: 29.5;T-47d: 25.8"	"Low region specificity"	"Detected in many"							HPA013835	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA013835: AB_1847214"	"unprognostic (3.25e-1)"	"unprognostic (4.41e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-2)"	"prognostic favorable (8.06e-5)"	0.8	0.4	0.3	4.0	0.7	0.3	5.1	1.2	0.5	9.3	6.1	26.9	36.9	2.2	4.6	54.5	8.2	8.2	0.3	0.3	0.2	34.1	32.5	19.0	0.9	0.4	0.2	0.4	44.0	20.7	15.9	3.5	0.5	9.1	10.5	0.4	24.8	8.9	0.1	41.9	30.6	0.5	0.1	0.8	31.1	0.4	0.2	0.8	16.2	0.0	5.4	6.4	17.6	0.5	57.9	7.0	0.0	0.2	0.0	0.1	35.1	0.0	0.0	0.0	0.0	38.1	23.8	0.3	22.1	0.0	0.3	36.9	0.4	12.5	0.0	0.0	0.4	0.1	0.2	21.5	0.0	0.1	0.1	0.0	27.8	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.0	15.1	0.2	0.4	1.3	33.1	0.0	0.0	0.0	0.7	16.5	24.0	0.0	0.1	0.2	29.5	0.1	1.7	25.8	0.2	0.0	0.1	0.4	0.2	0.1	0.7	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.3	3.1	4.6	2.2	0.0	1.0	9.2	3.6	0.3	0.0	0.0	0.0	3.4	1.9	0.3	0.7	1.2	0.5	0.3	0.2	0.4	0.2	0.5	0.1	0.2	0.5	0.2	35.3	38.0	0.0	2.2	72.1	64.6	81.3	21.1	0.0	43.6	19.9	0.3	71.4	64.0	31.3	0.0	28.1	0.9	160.9	46.9	113.0	0.0	43.8	4.0	1.8	16.8	3.2	0.1	101.5	9.8	2.0	34.7	58.3	1.3	0.1	0.4	31.8	2.5	0.0	0.0	60.2	63.1	1.0	6.2	0.0	0.0	1.3	7.2	0.0	2.7	0.9	0.0	0.0	0.1	149.9	177.3	0.0	3.1	94.4	86.8	44.5	36.3	0.5	0.0	0.0	4.2	1.1	0.4	45.0	139.5	56.2	3.2	0.2	52.0	243.6
DLG5	"KIAA0583, P-dlg"	ENSG00000151208	"Discs large MAGUK scaffold protein 5"	Q8TDM6	10	77790791-77926755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 112.5;Glandular and luminal cells: 139.6;Horizontal cells: 186.7;Syncytiotrophoblasts: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001746			Supported	"Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA001746: AB_2666418"	"unprognostic (1.36e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (8.48e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.13e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.74e-2)"	11.9	51.8	8.3	0.5	8.1	0.2	19.4	7.7	8.5	24.4	9.4	28.6	0.3	25.1	16.3	19.7	17.7	1.1	7.4	8.1	8.6	8.8	4.6	8.6	0.4	17.2	9.6	19.5	11.1	6.1	33.9	2.4	10.2	31.2	1.7	4.2	16.8	2.9	26.3	36.3	12.5	2.2	10.1	4.1	16.4	6.2	8.6	1.2	22.3	0.9	1.4	20.3	22.2	10.3	5.7	0.1	4.5	4.9	6.8	2.9	2.9	6.3	3.7	1.1	1.1	0.0	3.8	0.0	6.0	3.2	1.9	6.0	2.3	3.4	4.2	2.0	7.5	1.1	0.0	7.0	6.5	0.4	1.5	3.3	8.1	0.2	9.8	8.2	0.4	0.1	3.0	0.0	3.4	2.0	0.6	1.8	4.3	7.0	20.0	4.1	1.4	0.3	4.8	0.0	1.5	4.2	2.7	5.7	2.2	6.1	2.3	1.1	1.9	1.2	9.2	1.2	5.7	0.0	0.7	0.5	1.2	1.2	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	8.1	7.7	8.5	8.1	8.6	17.2	9.6	10.2	10.1	8.6	10.3	5.2	6.4	5.4	21.2	0.5	29.6	24.2	20.2	12.0	18.3	41.9	28.3	2.8	12.8	13.6	20.2	16.7	112.5	12.1	12.2	0.0	6.7	16.4	55.6	41.7	4.9	2.4	0.0	24.0	5.9	23.6	12.5	8.2	139.6	1.3	49.4	3.3	3.3	13.1	186.7	28.3	10.4	8.2	0.0	3.9	10.2	18.6	1.8	8.8	10.3	0.8	46.4	9.2	19.1	13.6	12.4	7.6	18.4	6.8	25.4	15.2	2.1	34.6	15.3	26.3	24.2	15.1	1.6	7.6	10.8	24.2	171.6	5.5	10.4	10.1	23.5
DPPA5	Esg1	ENSG00000203909	"Developmental pluripotency associated 5"	A6NC42	6	73353063-73354276	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 2.4;Spermatogonia: 1.4"	"Cancer enriched"	"Detected in single"	2209	"testis cancer: 347.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"SuSa: 6.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA055016, HPA064505"	Uncertain		Uncertain	"Cell Junctions"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Cell Junctions"		"HPA055016: , HPA064505: AB_2685275"															"unprognostic (1.85e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498177-31549008	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 105.3;parathyroid gland: 157.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.6;Pancreatic endocrine cells: 254.9;Undifferentiated cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 172.9;HaCaT: 269.2;HBEC3-KT: 201.2;hTERT-HME1: 212.1;OE19: 229.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		NA	NA		140000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavorable (8.22e-4)"	"prognostic favorable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	23.6	1.2	0.2	14.6	0.2	0.8	40.2	0.6	0.2	13.0	26.4	105.3	79.1	8.6	10.6	10.2	22.4	31.4	31.4	0.7	0.1	33.8	15.1	15.0	1.6	0.3	0.5	13.6	39.5	157.8	1.6	22.9	0.7	31.5	100.0	0.3	68.6	6.5	1.2	6.7	84.6	7.3	0.0	0.4	77.1	3.7	0.4	24.2	42.2	0.7	4.6	41.6	5.7	0.5	119.2	45.3	4.0	0.1	0.6	7.2	143.0	0.0	0.0	0.3	0.0	31.7	172.9	0.0	64.2	0.0	54.4	269.2	54.7	201.2	0.0	0.2	33.9	0.1	46.7	35.9	20.2	15.2	0.3	9.9	136.7	4.2	212.1	102.4	0.0	34.7	47.8	0.2	0.0	31.5	32.2	2.0	55.4	229.5	23.1	52.8	0.0	76.2	65.8	58.5	23.9	0.2	88.3	61.8	0.3	117.8	44.3	12.7	0.1	0.2	25.0	0.3	29.3	5.7	0.2	0.2	19.8	0.1	25.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.2	0.6	0.2	0.7	0.1	0.3	0.5	0.7	0.0	0.4	0.5	120.8	54.5	45.4	0.0	1.3	13.5	79.4	76.2	28.5	0.4	68.9	49.3	57.3	101.5	79.6	12.9	0.0	80.1	4.4	404.6	3.9	105.5	1.0	48.6	9.4	13.1	79.9	9.0	3.3	76.1	116.2	12.0	70.3	82.1	4.5	18.8	2.2	26.4	10.3	1.7	0.3	165.7	79.3	0.8	4.0	2.5	1.5	2.2	17.8	0.0	6.3	5.3	1.0	0.5	0.1	254.9	152.0	0.4	0.3	133.5	145.1	10.0	75.4	0.7	0.0	0.6	8.2	2.7	8.9	23.1	6.0	59.9	2.6	6.6	216.8	179.9
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541617-7586714	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 460.7;skin 1: 854.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 902.0;Cardiomyocytes: 729.7;Squamous epithelial cells: 1657.5;Suprabasal keratinocytes: 2018.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 278.0;HaCaT: 302.6;HBEC3-KT: 217.5;hTCEpi: 666.3;SuSa: 204.1"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 11.6"	"Region enhanced"	"Detected in many"		"spinal cord: 9.5"	"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		NA	NA		100000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645"	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favorable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.82e-4)"	5.2	11.6	4.2	7.0	1.8	0.6	65.8	2.5	3.5	151.0	19.3	46.0	52.0	5.4	27.5	460.7	16.3	7.8	84.9	3.4	0.9	22.4	41.9	6.1	3.7	1.6	2.0	2.0	111.5	54.9	9.0	63.3	1.5	29.9	43.5	21.2	125.1	11.7	3.4	854.8	42.3	2.9	2.4	3.2	48.1	1.5	2.2	37.1	41.5	0.6	78.7	13.1	286.1	0.9	132.2	38.9	0.0	0.1	5.6	8.2	278.0	25.5	21.8	12.4	12.0	110.8	33.5	0.1	35.8	40.9	10.0	302.6	46.1	217.5	2.2	0.1	54.1	0.0	21.5	149.5	0.0	0.6	0.9	1.9	666.3	11.0	121.7	30.0	0.0	0.6	0.2	0.2	22.0	61.4	0.1	1.0	5.6	62.6	19.6	0.1	0.1	32.9	45.3	34.8	12.6	0.3	28.5	59.9	0.2	204.1	71.0	0.3	0.0	4.8	1.2	0.3	0.3	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.8	2.5	3.5	3.4	0.9	1.6	2.0	1.5	2.4	2.2	0.9	7.6	51.3	17.0	0.0	7.5	902.0	164.5	157.3	278.3	4.4	184.5	126.4	729.7	97.2	197.5	60.7	14.6	273.0	1.2	357.1	1.9	160.6	1.8	306.5	42.4	46.9	174.6	0.0	0.1	111.9	273.1	51.2	237.0	560.1	3.8	532.2	4.6	186.6	27.5	0.0	0.9	204.7	111.9	1.9	77.8	1.3	0.9	5.9	101.4	3.7	2.6	14.7	0.0	0.0	0.1	167.4	284.2	0.0	5.7	204.0	180.7	12.0	176.6	28.6	0.0	0.4	67.4	1.3	2.7	1657.5	2018.0	385.7	8.1	0.3	247.8	269.9
EDA2R	"EDA-A2R, EDAA2R, TNFRSF27, XEDAR"	ENSG00000131080	"Ectodysplasin A2 receptor"	Q9HAV5	X	66595637-66639298	"Predicted membrane proteins"	Differentiation	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 8.3;Microglial cells: 5.6;Oligodendrocytes: 6.4;Theca cells: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 24.3;HSkMC: 33.3;LHCN-M2: 31.8;SuSa: 25.2"	"Not detected"	"Not detected"							HPA054522			Approved	"Cell Junctions"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	"Cell Junctions"		"HPA054522: AB_2682516"	"unprognostic (1.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (4.15e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.08e-1)"	2.1	5.7	1.7	0.5	2.4	0.0	3.0	1.9	2.1	6.1	3.8	2.2	0.3	5.7	4.2	2.4	4.3	3.3	2.1	1.7	1.8	1.2	0.8	2.6	0.5	2.5	1.8	7.5	3.1	3.0	3.4	1.1	2.7	4.0	4.9	0.7	2.5	5.4	2.4	1.5	1.1	5.2	2.2	1.2	0.8	1.4	2.3	2.6	5.6	0.9	0.4	2.4	4.3	3.7	0.0	16.4	15.0	0.0	21.0	24.3	0.2	22.5	24.0	2.1	3.3	0.0	0.0	8.3	0.0	14.6	0.0	0.1	0.0	8.6	7.3	0.0	7.8	0.0	0.5	11.0	3.7	0.0	0.1	33.3	20.0	16.4	15.1	20.2	0.5	0.4	0.8	8.4	31.8	1.9	0.4	0.0	5.6	0.0	0.0	0.0	2.0	0.0	1.5	0.0	0.0	2.7	0.0	0.0	0.0	25.2	0.5	0.3	17.3	0.0	12.0	0.0	0.2	0.0	0.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.4	1.9	2.1	1.7	1.8	2.5	1.8	2.7	2.2	2.3	3.7	0.5	3.2	0.0	0.7	0.8	0.3	1.0	1.5	2.8	0.1	1.2	1.7	0.5	1.5	1.4	1.8	0.0	1.2	0.1	0.0	0.0	0.2	0.0	0.5	1.2	0.6	1.2	0.0	0.0	0.6	1.3	2.5	0.5	0.2	0.0	8.3	0.7	0.0	0.2	0.0	0.3	0.5	2.0	0.0	0.3	0.0	1.8	0.1	1.8	5.6	0.0	1.5	1.0	2.0	6.4	0.6	0.3	0.4	0.0	1.1	0.2	0.4	1.0	0.0	0.0	3.6	1.6	0.0	0.2	0.7	0.6	0.7	0.6	5.0	0.5	0.6
FAT3	"CDHF15, CDHR10, KIAA1989"	ENSG00000165323	"FAT atypical cadherin 3"	Q8TDW7	11	92224818-92896473	"Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 19.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 265.8;Excitatory neurons: 512.9;Inhibitory neurons: 149.2;Oligodendrocyte precursor cells: 88.4"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.3;fHDF/TERT166: 2.2;NTERA-2: 2.5;SuSa: 2.2;U-2 OS: 2.1;U-251 MG: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026878, HPA074824"	Uncertain		Approved	"Cell Junctions"		NA	NA		4700		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"		"HPA026878: AB_1848430, HPA074824: "	"unprognostic (5.00e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.76e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.66e-4)"	"unprognostic (8.83e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.25e-1)"	0.5	0.0	5.5	0.0	19.3	0.0	0.1	1.3	9.0	0.6	0.0	0.2	0.0	0.6	0.6	0.1	0.6	0.0	0.2	4.0	15.5	0.2	0.0	1.2	0.0	0.5	4.7	0.5	0.0	0.0	2.9	0.1	1.9	2.0	0.1	1.3	0.0	3.8	0.1	0.2	0.0	0.1	0.8	0.1	2.2	0.7	7.5	0.1	0.0	0.2	0.2	2.3	1.0	1.0	0.0	0.3	7.3	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	1.4	2.2	0.0	1.2	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	2.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	19.3	1.3	9.0	4.0	15.5	0.5	4.7	1.9	0.8	7.5	1.0	0.0	0.0	0.0	265.8	0.0	0.1	0.3	0.9	0.0	20.8	0.1	0.5	1.8	0.0	0.1	14.7	0.0	0.1	0.0	0.1	0.0	0.7	4.8	0.1	0.2	0.2	0.0	0.0	512.9	0.0	0.1	1.9	0.0	0.0	0.0	3.7	1.4	0.0	0.1	0.0	149.2	0.0	24.4	0.0	0.0	3.8	1.2	0.3	0.0	13.1	0.0	0.8	0.0	88.4	7.0	0.2	0.0	7.5	0.0	0.6	0.0	0.0	0.0	1.7	0.0	2.5	4.4	1.0	6.5	0.1	0.0	0.0	0.0	44.8	0.0	0.1
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 9.9;brain: 26.7;parathyroid gland: 12.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.6;Exocrine glandular cells: 30.1;Intestinal goblet cells: 24.5;Ionocytes: 26.4;Late spermatids: 36.1;Pancreatic endocrine cells: 28.6;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.7;MCF7: 32.8;OE19: 22.9;RPTEC TERT1: 24.4;THP-1: 12.5;U-2 OS: 14.1;U-251 MG: 13.5"	"Group enriched"	"Detected in many"	4	"basal ganglia: 17.6;hippocampal formation: 68.4"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 57.3"	HPA055353	Approved		Approved	"Cell Junctions"		NA	NA		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"		"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.1	9.9	8.0	0.0	1.8	0.0	0.5	0.0	15.8	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.2	0.5	26.7	1.4	0.1	0.0	2.1	0.0	8.3	6.3	0.1	0.0	12.5	0.1	0.9	5.2	0.1	0.7	1.3	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.1	6.6	5.4	0.0	0.0	0.0	0.0	0.9	0.1	2.7	0.3	3.5	1.2	0.0	0.1	0.0	0.0	5.9	8.7	0.4	1.2	0.0	3.7	0.0	2.3	0.3	6.3	2.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.4	0.2	0.3	0.0	0.1	3.9	0.0	13.7	0.0	0.0	0.7	0.0	0.0	32.8	0.0	2.8	2.1	22.9	0.6	0.0	5.7	0.4	24.4	0.0	0.2	0.0	1.1	0.1	0.8	0.9	2.0	12.5	0.0	1.3	14.1	0.1	13.5	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	8.0	1.8	0.0	15.8	26.7	1.4	8.3	6.3	5.2	0.0	5.4	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.9	5.0	0.0	3.2	0.8	0.0	1.3	0.0	2.3	1.8	0.0	11.6	0.0	10.4	0.0	0.3	19.6	0.0	0.1	0.4	0.0	0.0	0.3	30.1	0.9	0.9	0.0	0.0	0.0	0.8	0.0	0.0	1.1	3.3	0.3	24.5	26.4	0.0	0.0	36.1	0.6	0.5	0.0	1.9	0.4	0.6	0.0	0.0	0.1	28.6	6.3	3.4	0.0	0.7	2.5	0.1	2.1	0.2	0.0	0.0	0.8	9.5	16.3	0.0	0.0	4.0	0.0	0.9	6.7	1.5
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA, SLC49A1"	ENSG00000162769	"FLVCR heme transporter 1"	Q9Y5Y0	1	212858275-212899363	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.4"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"	"Cell Junctions"		"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	2.1	2.4	3.4	3.1	2.8	6.2	3.1	5.0	3.7	2.9	2.7	3.4	9.7	2.5	4.9	2.1	2.4	2.0	1.6	3.2	4.4	2.4	1.8	2.4	2.9	4.5	4.1	2.4	2.6	3.6	6.9	2.4	5.3	3.4	2.8	7.0	1.9	1.8	1.0	2.9	19.4	1.7	2.5	2.6	4.8	2.8	4.3	2.6	2.2	0.6	2.2	2.3	2.3	4.2	8.4	11.0	16.8	5.1	2.8	3.4	31.3	2.4	1.8	4.8	2.9	16.1	15.2	9.1	4.4	1.7	10.2	12.5	18.2	5.4	4.7	5.4	8.0	5.4	10.4	14.9	3.2	14.5	8.4	2.7	3.5	5.2	6.6	2.5	3.8	6.4	14.7	7.4	3.2	3.2	4.1	7.2	55.3	11.1	7.7	9.0	15.4	10.6	6.0	8.0	18.1	12.7	11.2	11.1	10.4	13.8	18.2	6.7	2.2	2.3	5.6	7.7	11.2	4.6	9.9	10.8	3.5	8.3	2.9	0.5	0.2	1.5	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.3	0.3	0.3	0.7	0.2	0.2	0.4	0.4	0.0	3.4	2.8	5.0	3.7	3.2	4.4	4.5	4.1	5.3	2.5	4.3	4.2	6.7	12.8	16.0	12.4	8.3	14.3	8.8	6.9	9.6	24.0	10.3	9.5	4.1	14.3	12.1	20.2	35.5	3.9	6.8	13.7	1.9	5.5	4.7	7.0	7.8	9.3	32.4	9.5	28.8	13.4	6.7	8.8	17.3	7.6	7.0	20.1	10.0	9.2	6.5	16.8	39.4	10.6	10.2	10.1	9.6	6.8	6.2	9.0	5.4	9.4	10.5	5.8	4.1	24.1	28.7	8.9	12.0	2.6	6.5	11.9	73.7	4.6	10.1	31.8	6.6	18.0	7.2	10.4	6.8	7.0	9.2	2.5	8.3	5.1	8.2	4.3
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759740-34762327	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 43.1"	"Group enriched"	"Detected in some"	4	"Basal prostatic cells: 31.1;Pancreatic endocrine cells: 37.0;Urothelial cells: 102.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;HaCaT: 12.2;HBEC3-KT: 8.3;hTCEpi: 5.7;OE19: 4.5;RPTEC TERT1: 4.8;RT4: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.0	0.0	0.0	0.3	0.1	0.0	2.6	0.0	0.2	0.7	0.0	0.2	0.0	0.0	5.5	2.3	0.2	4.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.5	1.0	0.2	43.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.1	0.0	2.3	7.9	1.4	0.0	9.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.0	0.1	12.2	0.0	8.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	4.8	5.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	31.1	13.9	1.2	0.0	0.3	0.1	0.1	0.0	5.7	0.0	0.0	0.1	0.1	0.3	0.0	3.7	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	37.0	1.3	0.0	0.0	12.9	0.1	0.0	6.8	0.0	0.0	0.0	0.7	0.0	0.0	3.5	6.0	0.3	0.1	0.0	0.4	102.6
GJB6	"CX30, DFNA3, ED2, EDH, HED"	ENSG00000121742	"Gap junction protein beta 6"	O95452	13	20221962-20232365	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.6;esophagus: 195.4;vagina: 139.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 58.8;Basal keratinocytes: 12.2;Basal respiratory cells: 15.6;Ionocytes: 12.2;Squamous epithelial cells: 31.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 145.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.6"	"Cell line enriched"	"Detected in some"	10	"RT4: 186.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014846			Supported	"Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA014846: AB_1847135"	"unprognostic (5.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"unprognostic (7.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.96e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.14e-11)"	"unprognostic (8.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.35e-3)"	"unprognostic (5.04e-2)"	0.5	0.2	55.8	0.3	59.4	95.6	3.8	73.0	80.9	65.9	36.0	0.0	0.0	0.9	0.2	195.4	0.4	1.3	0.1	50.2	63.5	0.0	0.1	0.3	0.8	60.0	71.8	0.0	0.1	0.0	4.4	0.0	57.5	0.2	0.1	0.0	34.5	0.0	0.1	56.8	0.2	0.0	47.7	0.2	0.3	1.4	76.3	37.6	5.3	0.0	15.4	10.3	139.3	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	4.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	186.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	1.1	0.6	0.5	0.0	0.0	0.0	2.6	0.2	55.8	59.4	73.0	80.9	50.2	63.5	60.0	71.8	57.5	47.7	76.3	42.7	0.0	0.0	0.0	58.8	0.0	12.2	1.7	15.6	4.0	0.0	0.0	0.1	0.6	0.0	4.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.9	5.8	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	12.2	0.0	0.4	4.6	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.1	0.3	31.0	3.8	0.0	0.3	0.0	0.0	2.4
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703357	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;skin 1: 30.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 84.7;Basal respiratory cells: 52.0;Basal squamous epithelial cells: 120.1;Ionocytes: 87.5;Langerhans cells: 124.0;Suprabasal keratinocytes: 106.1"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 5.9"	"Immune cell enriched"	"Detected in many"	5	"neutrophil: 176.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 176.7"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 118.4"									HPA028660	Approved		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	22.2	0.3	0.1	9.8	0.2	22.1	7.6	0.1	5.9	8.9	0.2	0.7	0.9	0.2	0.3	40.8	0.7	0.8	0.9	0.3	0.1	3.9	2.9	11.9	0.6	0.1	0.1	0.1	0.2	5.5	0.3	4.5	1.2	3.4	0.3	0.2	14.2	14.7	0.2	30.2	1.0	0.3	0.1	25.9	1.5	2.7	0.2	10.5	0.5	1.9	10.2	6.9	14.0	0.1	4.5	0.4	0.1	0.1	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	118.4	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.1	3.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.5	0.2	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	38.7	2.5	2.6	0.0	5.3	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	176.7	0.0	23.9	0.0	0.0	1.4	0.1	0.2	0.1	5.9	0.3	0.1	0.1	0.1	1.2	0.1	0.2	0.1	0.4	0.0	4.3	0.0	0.5	94.4	84.7	52.0	120.1	0.5	3.4	1.1	0.1	0.0	40.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	24.9	0.4	0.2	1.2	0.0	0.0	0.0	0.0	26.3	2.4	0.0	0.3	2.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	87.5	4.1	124.0	2.7	0.0	17.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	8.5	0.1	0.0	0.1	1.4	0.0	0.1	47.2	106.1	2.6	1.5	0.0	0.0	32.5
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716811	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;esophagus: 16.8;lymphoid tissue: 19.6;skin 1: 17.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 81.1;Basal respiratory cells: 57.3;Basal squamous epithelial cells: 159.4;Langerhans cells: 57.4;Squamous epithelial cells: 66.9;Suprabasal keratinocytes: 106.3;Urothelial cells: 66.1"	"Group enriched"	"Detected in some"	4	"cervical cancer: 2.1;head and neck cancer: 2.5;lung cancer: 1.0;urothelial cancer: 1.9"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 4.7"	"Group enriched"	"Detected in many"	6	"basophil: 58.6;neutrophil: 177.2;non-classical monocyte: 84.4"	"Group enriched"	"Detected in many"	50	"granulocytes: 177.2;monocytes: 84.4"	"Cell line enriched"	"Detected in some"	4	"RT4: 37.1"									HPA028660	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (2.32e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.28e-2)"	5.6	0.1	0.0	9.2	0.1	27.4	2.3	0.0	4.7	2.5	0.2	0.5	0.2	0.0	0.5	16.8	0.7	0.6	0.7	0.1	0.0	0.9	1.8	8.2	0.4	0.0	0.0	0.1	0.0	3.4	0.2	1.9	0.9	1.5	0.1	0.1	3.4	2.7	0.1	17.4	0.2	0.2	0.0	19.6	0.4	0.1	0.1	4.0	0.4	1.1	7.8	7.1	4.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	9.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	58.6	2.2	0.8	0.0	16.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	177.2	0.0	84.4	0.0	0.0	2.9	0.0	0.1	0.0	4.7	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	3.2	6.7	0.0	0.7	94.4	81.1	57.3	159.4	0.2	0.7	0.3	0.0	0.0	24.6	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	21.5	1.4	0.0	0.1	3.8	0.0	0.0	0.1	6.0	0.0	0.0	0.0	12.2	10.6	57.4	0.2	0.0	20.1	8.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	14.7	0.0	0.1	2.2	0.2	0.0	0.0	1.4	0.1	0.0	66.9	106.3	13.8	1.0	0.0	0.0	66.1
LDLRAD3	LRAD3	ENSG00000179241	"Low density lipoprotein receptor class A domain containing 3"	Q86YD5	11	35943981-36232136	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.4;Excitatory neurons: 68.6;Microglial cells: 104.9;Oligodendrocyte precursor cells: 308.6;Oligodendrocytes: 215.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 4.8;non-classical monocyte: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 63.7;RH-30: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038251	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Cell Junctions"		"HPA038251: AB_10675790"	"unprognostic (1.59e-3)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (9.34e-6)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (5.05e-8)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (2.14e-5)"	10.9	4.5	9.9	4.7	13.9	1.4	18.6	20.8	10.6	7.7	6.3	3.4	2.0	8.5	3.2	6.7	5.8	4.8	4.0	9.7	12.4	4.4	1.6	3.8	3.6	22.0	16.8	11.2	3.8	1.3	5.1	2.3	18.5	11.2	2.1	1.1	20.6	4.1	5.6	13.7	3.5	5.4	15.8	2.1	3.7	3.5	14.8	3.5	3.3	3.0	3.6	5.8	6.8	19.3	11.5	10.7	32.3	19.7	25.2	27.5	24.7	6.5	5.8	14.3	12.7	8.0	7.0	0.0	4.8	7.1	21.4	5.7	10.0	14.6	19.9	1.0	21.1	36.5	6.6	2.3	33.2	8.0	4.0	33.1	63.7	6.5	56.0	5.8	24.3	0.0	9.6	1.3	26.7	6.4	0.0	1.8	13.3	1.2	18.4	0.0	60.3	3.5	2.5	1.6	11.0	24.8	11.3	12.2	36.6	12.5	16.9	10.6	24.7	17.0	15.3	1.4	21.8	0.7	0.0	0.0	8.6	9.6	31.3	1.4	4.8	0.5	0.0	4.5	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	6.4	0.2	0.0	1.8	9.9	13.9	20.8	10.6	9.7	12.4	22.0	16.8	18.5	15.8	14.8	19.3	3.5	0.0	3.2	92.4	0.5	15.4	7.4	3.6	10.8	0.4	31.1	12.1	0.6	0.0	1.7	0.0	0.0	2.6	0.7	0.2	0.0	3.8	13.0	1.2	10.8	15.4	0.0	2.5	68.6	1.1	13.1	9.1	0.5	0.9	0.0	11.4	25.4	0.6	4.0	0.0	8.4	0.0	0.0	15.4	4.9	22.6	9.6	9.5	7.2	104.9	6.2	0.9	0.0	308.6	215.5	1.2	0.1	24.8	0.1	20.3	0.0	1.8	0.8	0.1	13.1	21.3	9.9	0.4	3.0	19.3	26.0	1.4	1.1	9.8	0.5	3.4
MAGI3	MAGI-3	ENSG00000081026	"Membrane associated guanylate kinase, WW and PDZ domain containing 3"	Q5TCQ9	1	113390515-113685923	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 34.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 266.0;Excitatory neurons: 206.7;Oligodendrocyte precursor cells: 128.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008444			Supported	"Cell Junctions"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"		"HPA008444: AB_2668069"	"unprognostic (4.07e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (4.29e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.60e-8)"	"unprognostic (1.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-2)"	2.8	3.3	5.4	2.3	7.1	0.2	7.6	2.8	8.6	3.5	2.8	9.2	5.9	4.9	6.5	7.6	3.7	3.8	3.2	5.4	5.4	7.1	6.2	13.2	1.2	4.0	7.4	6.0	10.7	3.9	4.7	7.4	6.6	4.2	8.2	34.8	4.3	2.6	1.5	1.9	7.5	4.6	2.0	2.3	11.6	4.1	5.2	2.4	10.9	2.4	3.8	2.7	4.0	5.9	8.8	10.8	10.0	4.5	4.4	6.4	2.7	6.1	3.0	4.8	5.3	9.5	2.6	0.4	4.5	5.7	4.1	3.9	9.1	4.7	5.9	9.5	8.6	4.0	9.6	4.3	1.0	3.3	5.6	3.4	2.3	5.1	11.0	5.7	6.7	4.2	4.7	8.4	6.6	5.9	5.2	0.9	3.5	15.3	6.3	7.3	16.1	1.0	5.5	4.0	8.9	9.0	7.4	12.1	2.2	12.3	6.3	1.7	11.6	7.8	9.8	7.1	8.7	3.1	2.8	0.0	4.1	1.5	6.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.4	7.1	2.8	8.6	5.4	5.4	4.0	7.4	6.6	2.0	5.2	5.9	14.0	266.0	103.2	106.7	1.3	10.8	9.1	9.2	21.1	97.1	27.1	16.0	9.2	14.3	60.7	12.9	50.1	16.0	1.0	51.8	7.9	10.9	39.4	11.2	19.7	11.9	13.8	3.2	206.7	10.7	2.4	14.9	37.8	15.9	6.3	12.1	12.1	14.4	4.1	40.4	100.1	23.6	4.1	2.2	6.9	28.4	10.2	2.6	12.4	92.8	0.5	35.6	0.0	128.7	17.7	13.5	40.2	11.3	8.8	9.5	32.6	5.3	17.5	45.6	13.1	13.4	10.7	23.8	9.6	23.4	7.5	5.5	4.1	8.7	28.9	10.5
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Urothelial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;CAPAN-2: 24.1;HaCaT: 18.9;RT4: 21.1;SCLC-21H: 26.7;T-47d: 18.3"	"Region enriched"	"Detected in some"	8	"cerebellum: 7.9"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.3	0.2	0.5	0.9	0.5	0.2	4.0	0.5	0.6	2.1	3.2	5.7	7.7	1.1	1.3	6.9	3.9	2.9	0.4	0.5	0.5	8.0	10.7	5.6	0.1	0.7	0.7	0.1	9.3	4.6	2.9	1.8	0.7	3.0	6.2	0.3	4.6	2.6	0.0	4.3	7.7	0.4	0.4	0.2	8.1	1.5	0.7	1.0	15.7	0.0	1.3	3.0	3.4	0.7	10.8	3.5	0.1	0.0	0.0	0.0	29.5	0.2	0.2	0.2	0.7	14.1	24.1	0.1	2.0	1.8	0.0	18.9	0.0	14.0	0.5	0.2	5.8	0.0	1.1	7.8	1.7	0.0	0.1	0.4	15.3	0.1	1.9	0.7	0.9	0.1	0.0	0.1	0.0	9.8	0.0	0.0	1.8	6.3	0.3	0.0	0.1	0.5	10.0	21.1	26.7	0.0	2.3	2.0	0.3	4.3	18.3	0.0	1.5	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.7	0.7	0.7	0.4	0.7	0.7	1.0	22.4	26.5	0.7	1.0	5.0	22.2	14.8	10.2	0.3	15.5	8.5	2.8	35.8	23.1	16.5	2.1	22.9	0.2	31.4	17.6	25.1	5.8	33.5	3.4	4.1	16.8	3.4	0.5	25.8	8.2	1.1	17.9	30.4	1.3	3.7	5.0	37.9	1.9	0.0	0.4	23.1	18.3	0.6	0.9	3.2	0.0	0.6	1.8	1.0	7.8	0.5	0.0	0.5	0.6	25.0	29.7	0.0	0.6	25.5	33.5	6.1	38.4	0.6	0.0	0.8	1.5	4.1	2.4	19.4	6.5	12.0	0.9	2.9	25.6	46.9
MEIOC	"C17orf104, FLJ35848"	ENSG00000180336	"Meiosis specific with coiled-coil domain"	A2RUB1	17	44656404-44690308	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 47.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 274.0;Late spermatids: 545.2;Spermatocytes: 242.4;Spermatogonia: 125.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 16.9;HMC-1: 25.4;NTERA-2: 8.7;SiHa: 9.5;SuSa: 12.0;THP-1: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027266	Enhanced		Uncertain	"Cell Junctions"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Cell Junctions"		"HPA027266: AB_1848900"	"unprognostic (5.82e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.83e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (8.89e-3)"	0.2	0.2	0.2	0.2	0.4	0.8	0.3	1.0	0.7	0.3	0.0	0.3	0.2	0.2	0.0	0.3	0.2	0.2	0.4	0.5	0.1	0.7	0.7	0.2	0.5	0.1	0.0	0.3	0.2	0.2	0.3	0.1	0.2	0.3	0.0	1.6	0.3	0.0	2.2	0.9	0.3	0.0	0.0	0.3	0.2	47.7	0.1	0.0	0.3	0.0	0.1	0.3	0.2	0.4	0.2	7.7	1.0	1.3	0.2	0.0	0.5	1.0	0.0	0.6	2.1	0.4	0.3	0.8	1.9	0.5	0.2	0.2	16.9	0.0	0.2	0.7	6.8	0.6	0.9	0.4	0.0	0.6	25.4	0.0	0.0	0.9	0.0	1.7	0.0	1.6	0.5	0.7	0.2	1.5	0.5	1.5	8.7	0.2	0.7	0.3	0.8	0.5	0.0	0.2	1.7	2.1	9.5	0.2	0.1	12.0	1.1	12.9	0.3	0.4	0.3	1.9	0.8	0.6	1.1	0.2	0.6	0.9	1.5	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.2	0.4	1.0	0.7	0.5	0.1	0.1	0.0	0.2	0.0	0.1	0.4	0.2	0.0	1.1	0.0	0.4	0.0	1.0	0.0	1.2	2.0	0.5	0.6	0.0	0.0	0.0	0.0	2.1	0.2	0.8	0.0	3.9	0.1	274.0	0.9	0.7	0.6	0.0	0.8	0.0	0.2	0.4	0.4	0.5	1.0	0.0	0.6	0.0	1.0	0.4	0.0	0.0	0.1	0.0	1.3	0.0	545.2	4.7	0.8	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	3.8	0.4	0.6	0.1	1.2	0.0	2.6	19.7	1.2	0.3	242.4	125.5	0.2	0.0	0.3	0.6	0.3	0.2	0.8
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253416-118264536	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 222.5;urinary bladder: 155.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 332.5;Basal prostatic cells: 504.4;Basal respiratory cells: 289.1;Squamous epithelial cells: 336.4;Suprabasal keratinocytes: 467.4;Urothelial cells: 489.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.6;intermediate monocyte: 9.2;myeloid DC: 17.0;neutrophil: 13.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.0;granulocytes: 13.2;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 120.9;EFO-21: 130.4;HaCaT: 166.9;RT4: 321.7;TIME: 351.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 38.8"	HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	28.6	4.7	2.5	11.9	2.1	0.7	19.6	2.3	4.8	56.7	5.2	31.1	17.0	16.9	38.5	222.5	46.4	33.5	7.2	2.3	2.6	26.4	23.2	47.0	2.3	3.2	3.0	3.8	13.5	27.1	10.7	1.7	3.2	48.6	30.8	0.9	58.0	69.5	4.7	38.8	11.3	14.7	3.6	4.6	37.0	0.9	3.4	18.1	30.3	1.0	52.6	155.9	120.5	2.8	65.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.0	120.9	0.3	130.4	0.0	0.6	166.9	0.0	38.9	0.0	0.2	9.5	0.1	1.7	35.8	0.0	0.0	0.4	0.0	90.2	0.0	3.0	0.0	86.8	0.8	0.0	0.2	0.0	51.3	0.2	0.2	1.6	34.2	0.1	0.0	0.0	6.4	14.9	321.7	0.1	0.0	5.8	61.4	0.0	0.5	26.1	0.7	351.9	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	2.3	11.6	3.0	0.1	9.2	1.3	0.0	0.6	0.4	17.0	0.0	0.8	0.9	13.2	0.4	1.4	0.3	0.2	3.8	2.5	2.1	2.3	4.8	2.3	2.6	3.2	3.0	3.2	3.6	3.4	2.8	5.9	83.3	123.3	0.0	0.2	332.5	504.4	289.1	127.5	0.0	29.0	17.4	3.4	30.0	221.1	128.8	0.0	1.7	0.5	52.0	0.0	39.4	0.0	91.6	18.8	33.6	5.3	3.6	0.0	51.1	0.2	8.2	29.6	194.0	7.0	0.0	45.3	16.5	0.8	0.0	0.0	6.3	81.4	6.4	27.0	0.3	0.0	7.8	21.4	1.9	4.9	0.0	1.0	0.0	0.0	68.2	20.8	0.0	1.2	186.3	3.3	6.9	65.2	0.0	0.0	0.3	9.2	0.2	0.7	336.4	467.4	17.8	5.4	0.0	33.4	489.7
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA063389: AB_2685001, HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.97e-5)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favorable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	12.3	11.3	7.1	10.8	10.3	28.9	10.2	12.8	8.8	9.0	5.0	11.1	10.8	8.9	53.5	10.3	12.3	10.1	23.9	10.4	6.2	12.8	13.1	16.8	12.3	9.9	7.0	19.7	11.4	6.6	17.7	7.1	9.4	10.2	8.7	12.6	6.8	6.7	17.9	13.4	14.7	10.8	5.1	18.3	14.6	10.9	8.0	7.9	16.3	16.8	12.2	10.3	7.9	8.9	2.2	9.4	10.9	12.3	10.2	15.1	2.0	5.2	14.6	6.0	5.1	8.1	13.2	18.0	3.6	7.5	16.3	4.1	8.1	7.7	2.4	9.3	6.8	13.4	13.3	3.2	13.7	7.4	16.4	13.6	6.1	8.0	6.4	10.0	10.7	17.2	44.1	11.0	6.7	3.3	8.2	3.5	3.6	9.5	3.0	8.9	6.0	20.3	8.8	11.7	10.5	17.6	8.1	7.8	10.9	6.2	12.9	11.7	8.5	6.0	4.9	7.2	1.6	6.4	9.4	32.8	7.6	16.8	5.6	0.7	2.3	1.1	2.7	4.3	0.9	1.6	0.8	1.4	1.7	2.3	1.2	1.4	2.5	2.0	6.1	0.9	0.6	1.6	7.1	10.3	12.8	8.8	10.4	6.2	9.9	7.0	9.4	5.1	8.0	8.9	15.9	25.6	48.0	8.1	18.3	8.4	6.8	11.9	15.9	0.0	17.9	10.8	37.0	11.5	13.0	27.6	0.0	5.1	6.0	44.2	1.9	8.9	18.2	32.0	25.8	16.9	12.1	29.5	15.8	25.3	3.3	21.0	52.5	55.5	8.2	10.7	37.5	23.4	22.2	0.0	15.2	18.0	6.1	39.3	39.9	42.4	18.3	32.1	12.4	16.9	26.5	0.0	20.6	9.0	13.3	21.9	20.6	9.1	10.3	10.2	36.0	17.2	12.3	0.0	19.7	22.8	23.3	6.8	5.2	15.0	9.2	2.9	10.6	21.3	18.6	9.6
MUC3A	MUC3	ENSG00000169894	"Mucin 3A, cell surface associated"	Q02505	7	100949534-100968347	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 13.8;intestine: 41.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 220.6;Intestinal goblet cells: 114.2;Paneth cells: 157.1;Proximal enterocytes: 360.1;Undifferentiated cells: 129.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 16.4;pancreatic cancer: 14.0;stomach cancer: 29.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.3;CAPAN-2: 2.4;MCF7: 1.6;OE19: 3.7"	"Region enriched"	"Detected in many"	7	"cerebellum: 16.5"					"HPA010871, HPA047868"	Uncertain		Uncertain	"Cell Junctions"	"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Cell Junctions"		"HPA010871: AB_1854201, HPA047868: "	"unprognostic (1.12e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.50e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.51e-2)"	1.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.6	0.0	0.0	9.4	41.7	0.0	0.0	0.0	0.0	13.8	3.2	0.0	0.8	0.2	8.7	0.2	0.3	0.0	0.3	0.0	0.5	0.8	0.0	0.0	0.0	3.1	11.9	0.0	0.1	0.0	5.0	0.1	33.5	0.8	0.0	0.1	2.7	0.1	0.1	9.9	0.8	0.5	0.3	0.4	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	7.3	2.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.6	0.0	0.0	1.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.2	0.0	27.2	0.0	0.0	0.0	1.0	0.4	2.1	28.6	0.0	1.8	0.0	0.7	0.0	220.6	0.0	18.8	0.8	0.0	0.1	0.8	10.3	0.0	0.1	28.8	1.1	0.4	15.8	0.0	0.0	0.0	0.4	5.3	0.3	0.0	0.0	114.2	0.0	0.8	0.0	0.4	0.3	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	28.9	157.1	0.0	0.0	65.7	360.1	0.3	0.0	0.0	0.0	0.4	6.4	0.8	6.8	0.0	0.1	0.3	0.4	0.0	129.5	21.3
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375200-17735994	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Inhibitory neurons: 264.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;RPTEC TERT1: 19.2;RT4: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: AB_2686789"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	3.2	4.1	2.9	1.3	2.4	0.4	2.8	0.0	4.2	6.1	6.8	4.1	0.8	4.8	2.8	1.8	2.7	1.6	0.9	1.8	2.5	5.1	0.2	1.1	0.5	3.3	2.8	3.5	0.5	0.3	2.8	2.6	3.0	3.4	1.6	7.8	2.0	2.7	0.4	2.3	1.5	2.5	1.7	1.0	2.2	2.5	3.8	2.2	2.6	0.7	0.5	4.0	3.7	0.9	7.9	3.1	5.5	0.0	0.1	0.2	8.7	3.5	2.4	1.5	0.8	0.3	1.5	0.5	12.7	2.4	7.5	6.8	3.5	4.4	2.2	0.1	1.1	0.0	5.4	0.0	0.0	0.0	0.0	0.7	3.1	0.1	6.8	6.7	0.0	0.0	0.0	0.0	0.8	3.8	0.0	0.0	6.7	3.6	2.0	0.0	0.0	0.3	19.2	12.0	1.4	2.8	9.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	8.0	0.1	8.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	2.9	2.4	0.0	4.2	1.8	2.5	3.3	2.8	3.0	1.7	3.8	0.9	0.6	3.2	0.0	22.5	0.0	8.3	10.6	4.6	8.6	11.4	2.0	2.4	1.7	0.0	14.7	1.8	22.9	6.0	0.1	1.3	5.9	0.8	0.9	12.4	20.1	3.5	4.2	0.0	40.1	2.2	5.4	6.1	3.6	25.0	0.0	0.2	0.7	0.0	1.4	3.3	264.4	1.9	2.0	4.6	2.6	2.3	16.8	2.4	3.6	40.3	5.0	11.9	0.0	14.1	8.1	6.8	2.4	31.2	0.0	7.0	0.9	7.8	8.2	18.9	6.6	2.0	11.9	0.3	0.6	5.1	3.8	2.6	0.9	4.5	4.3	12.8
NUMB	C14orf41	ENSG00000133961	"NUMB endocytic adaptor protein"	P49757	14	73275107-73458617	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 290.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002874, CAB011478"	Approved		Enhanced	"Cell Junctions"		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"		"CAB011478: AB_443023, HPA002874: "	"unprognostic (5.28e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.14e-2)"	"prognostic favorable (2.32e-6)"	"unprognostic (9.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.87e-1)"	35.6	25.9	17.3	37.7	19.2	35.5	33.0	20.4	23.4	34.3	22.0	46.3	46.6	35.6	25.9	40.0	39.0	41.7	28.8	20.9	17.6	41.3	52.1	52.8	24.7	20.3	19.5	33.9	37.3	40.5	20.2	44.4	19.7	29.5	42.2	20.4	36.8	31.6	21.1	32.6	47.4	37.6	18.1	40.4	36.8	20.3	19.4	27.6	39.0	24.1	30.9	40.5	34.0	18.2	70.2	46.9	33.3	30.2	65.8	99.6	45.3	64.9	87.2	51.2	54.1	57.0	86.0	31.9	39.7	80.7	37.8	45.2	39.8	66.6	77.2	48.9	22.2	25.5	28.2	37.3	69.7	23.7	57.5	56.0	70.3	126.2	74.8	56.2	112.3	49.2	47.0	37.1	65.6	62.9	43.3	32.8	15.4	78.9	50.1	27.6	46.7	21.6	71.2	105.3	13.6	35.3	81.0	54.2	33.4	55.9	81.3	34.5	108.8	76.2	42.7	49.3	28.2	30.9	38.9	29.2	153.1	27.4	34.3	91.9	93.3	96.8	12.6	76.4	13.2	22.6	12.7	14.0	68.7	21.4	12.9	11.8	290.3	12.8	102.8	12.8	17.9	64.5	17.3	19.2	20.4	23.4	20.9	17.6	20.3	19.5	19.7	18.1	19.4	18.2	54.4	64.1	49.0	108.4	53.6	42.8	27.7	38.6	42.1	30.7	38.4	26.0	22.0	44.3	50.0	55.2	81.3	26.0	29.9	59.3	25.4	27.9	11.9	68.2	35.0	59.2	40.7	22.9	151.1	26.4	31.0	37.5	43.8	56.6	24.1	26.3	52.1	51.0	42.6	15.2	78.8	39.4	36.7	91.5	109.7	8.1	45.1	94.1	46.2	141.5	117.3	42.6	39.1	62.4	81.8	46.9	39.3	36.9	40.9	37.1	64.7	43.2	56.9	46.4	26.3	22.8	29.7	59.2	32.7	35.6	46.5	34.3	25.6	16.7	37.5	44.6
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545475-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 490.7;Microglial cells: 183.6;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;BJ hTERT+: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	9.1	2.8	6.0	1.7	7.3	0.0	5.5	5.3	5.3	4.9	9.3	12.6	3.6	5.1	3.7	4.0	6.5	4.5	4.0	4.6	9.2	6.9	3.4	5.4	2.1	9.3	12.2	7.3	4.9	9.2	1.9	4.4	8.3	4.8	5.5	2.5	3.0	5.2	2.7	4.5	4.2	5.2	8.4	3.1	4.5	3.8	8.0	1.4	5.6	3.6	2.5	5.9	4.0	7.4	2.5	2.1	6.3	2.3	17.8	8.9	3.4	3.8	12.5	3.5	3.8	6.2	1.7	0.0	4.3	7.8	2.8	0.3	0.8	1.0	3.6	0.2	2.9	8.8	5.2	0.0	1.8	0.0	0.5	3.4	1.7	1.2	5.2	5.3	5.2	0.8	0.2	0.1	4.5	1.0	0.0	0.0	0.8	0.9	0.5	0.0	2.7	2.1	3.7	2.5	0.7	2.0	2.0	1.9	1.7	6.2	3.1	0.0	10.9	2.7	1.7	5.5	1.8	0.0	0.0	0.0	2.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.3	5.3	5.3	4.6	9.2	9.3	12.2	8.3	8.4	8.0	7.4	9.5	9.6	8.6	490.7	0.5	11.0	3.3	2.4	6.8	0.5	5.6	5.8	10.8	15.7	14.5	29.5	0.0	3.2	0.2	12.4	0.0	8.7	76.6	8.5	4.0	6.8	6.0	0.8	5.6	2.4	0.2	16.2	11.7	7.4	1.3	14.1	8.2	4.5	0.5	5.0	50.8	9.2	2.0	1.0	4.3	26.0	31.1	0.6	7.2	183.6	0.1	9.7	0.0	159.3	104.2	6.5	15.9	57.9	1.4	5.0	9.4	4.8	17.0	0.3	19.7	23.5	9.6	1.4	2.9	3.5	4.7	1.1	1.0	2.3	8.0	5.3
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"liver: 258.8"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 168.7"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"MCF7: 8.1;T-47d: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		87000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 6: T47d - Mammary gland"	"Cluster 2: Hepatocytes - Metabolism"	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	258.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	5.7	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.4	0.4	0.2	1.6	1.7	1.6	0.2	0.9	0.8	0.1	0.0	2.2	2.3	1.6	0.5	5.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.2	0.5	0.0	0.0	4.1	1.5	0.2	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.9	168.7	0.3	0.0	0.4	0.0	0.0	2.2	0.0	3.1	0.3	1.9	8.8	0.0	1.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	14.1	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.1	0.0	7.6	0.0	0.0	0.1
PLEKHG4	"ARHGEF44, DKFZP434I216, SCA4"	ENSG00000196155	"Pleckstrin homology and RhoGEF domain containing G4"	Q58EX7	16	67277510-67289499	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 42.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 13.6;Granulosa cells: 13.3;Spermatocytes: 33.2;Spermatogonia: 21.5;Theca cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.3"	"Not detected"	"Not detected"			HPA055696			Approved	"Cell Junctions"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Cell Junctions"		"HPA055696: AB_2682889"	"unprognostic (2.63e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.88e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.06e-3)"	"unprognostic (4.48e-2)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (6.72e-9)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.01e-2)"	7.9	4.6	1.8	3.2	2.6	1.5	9.5	2.6	1.9	6.2	1.3	4.5	4.1	6.0	1.2	4.8	4.0	4.3	1.4	1.8	2.2	3.2	0.4	4.5	4.4	2.8	2.7	17.4	5.8	1.8	3.3	5.1	2.7	2.9	3.0	1.7	6.1	1.7	1.7	9.0	4.4	2.9	2.4	8.4	2.7	42.3	2.6	4.2	4.3	1.9	3.0	3.2	5.7	3.8	6.1	11.4	0.7	6.7	5.7	53.7	8.7	13.9	18.6	13.8	22.7	32.9	5.4	17.1	39.5	13.0	4.7	0.2	8.4	0.8	9.9	3.0	4.5	33.8	30.8	8.2	17.5	20.3	26.2	40.5	6.6	46.3	0.5	11.6	27.5	54.6	27.6	0.4	0.2	4.7	26.0	6.8	5.1	5.0	12.0	0.1	0.1	17.6	6.5	1.4	3.6	20.4	46.9	3.6	19.7	2.1	2.6	14.4	41.9	6.7	24.0	48.8	0.4	39.3	43.0	16.3	27.8	0.6	8.4	0.0	0.0	0.0	0.2	0.2	0.4	0.1	0.2	0.3	0.1	0.0	0.5	0.3	0.0	0.1	0.1	1.1	0.4	0.3	1.8	2.6	2.6	1.9	1.8	2.2	2.8	2.7	2.7	2.4	2.6	3.8	2.7	3.2	2.6	1.0	0.7	2.8	0.6	0.9	3.4	0.8	9.5	13.6	4.2	1.5	3.3	1.8	0.0	0.4	3.1	1.5	0.0	0.9	1.4	0.6	4.1	1.9	1.2	0.8	0.6	0.4	0.4	6.6	1.1	0.6	3.8	13.3	1.4	0.1	0.8	0.0	0.9	2.7	0.0	1.0	0.5	2.7	6.2	0.9	0.0	3.7	0.2	3.2	1.0	0.0	3.6	1.1	2.5	1.5	0.6	1.2	1.2	0.1	1.0	6.5	6.6	4.0	2.4	33.2	21.5	2.0	1.3	0.3	2.7	17.6	4.1	0.5
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990700	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 31.0;pituitary gland: 10.6;prostate: 11.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Alveolar cells type 2: 103.2;Enteroendocrine cells: 293.8;Pancreatic endocrine cells: 92.8"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 125.8;BJ hTERT+: 48.4;fHDF/TERT166: 45.8;TIME: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Cell Junctions"		"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.0	3.0	11.3	0.6	8.6	0.2	0.7	2.9	14.9	0.0	0.0	1.6	0.7	0.1	0.2	0.0	0.2	1.3	0.0	10.9	23.0	0.5	0.7	0.0	0.1	11.4	17.5	1.5	1.0	0.0	10.6	1.6	31.0	11.0	2.3	1.7	0.2	0.1	0.5	1.9	0.9	0.3	2.3	0.1	1.2	0.3	19.5	0.2	0.0	0.0	0.1	0.1	0.1	3.4	1.8	8.5	1.2	1.3	0.2	2.3	0.2	125.8	48.4	24.8	12.0	10.4	3.7	0.6	2.0	45.8	3.6	0.1	15.4	13.0	41.7	0.0	1.1	0.1	0.6	3.4	2.1	0.0	0.1	1.1	0.4	41.1	9.4	15.4	7.8	1.1	0.4	0.4	27.9	0.3	0.1	0.1	19.9	2.4	1.2	0.3	0.2	0.2	4.0	0.8	4.3	1.1	0.1	0.3	0.1	24.6	0.2	0.3	97.9	24.0	8.8	0.5	41.5	0.2	0.6	0.4	21.9	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	11.3	8.6	2.9	14.9	10.9	23.0	11.4	17.5	31.0	2.3	19.5	3.4	1.4	147.4	103.2	0.3	1.1	2.4	6.2	0.3	0.0	5.0	2.2	3.4	0.7	12.8	27.9	0.0	2.1	0.5	0.4	2.0	3.9	4.0	2.4	1.5	1.3	8.2	293.8	0.0	6.6	18.4	0.3	13.9	3.6	1.4	7.6	27.9	0.7	2.7	0.3	0.0	48.1	14.7	14.2	1.3	1.2	1.3	0.6	3.7	1.8	1.0	1.0	31.2	1.0	1.5	1.5	92.8	1.4	1.2	2.3	18.8	1.4	0.2	29.5	3.7	0.0	4.1	4.8	10.4	4.3	0.0	1.4	4.0	3.3	1.1	1.6	2.7
RD3L	"TDRD9-AS1, TDRD9AS1"	ENSG00000227729	"Retinal degeneration 3 like"	P0DJH9	14	103940426-103942561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"heart muscle: 23.3;retina: 13.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 78.5;Cardiomyocytes: 40.8;Cone photoreceptor cells: 29.2;Horizontal cells: 26.9;Rod photoreceptor cells: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 10.4"	"Low region specificity"	"Detected in all"			HPA067971	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"		"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"		"HPA067971: AB_2685935"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.5	0.0	0.0	40.8	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHKBP1	"PP203, Sb1"	ENSG00000160410	"SH3KBP1 binding protein 1"	Q8TBC3	19	40576853-40591399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 127.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041887	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Cell Junctions"		"HPA041887: AB_10794639"	"unprognostic (1.26e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.52e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.64e-2)"	33.7	32.1	14.6	39.4	16.5	66.8	29.1	15.3	19.4	35.3	15.4	34.9	18.4	34.4	7.7	47.0	33.3	14.4	29.6	14.8	16.1	42.3	30.0	52.3	40.9	19.7	16.6	25.2	37.6	15.8	21.8	14.3	17.2	35.1	10.4	1.3	31.7	13.5	15.8	32.6	45.5	15.8	15.6	127.1	41.2	17.2	19.4	29.5	35.0	6.8	25.0	36.5	35.6	20.0	70.9	107.1	21.1	30.2	18.0	20.0	39.7	26.8	39.9	41.1	56.2	46.9	47.5	73.9	52.1	42.3	35.0	30.2	27.3	50.8	19.4	114.6	65.1	53.9	29.4	32.1	38.8	50.6	147.9	32.4	36.2	37.4	23.3	30.0	60.8	81.7	30.7	60.2	32.0	61.6	52.1	70.5	15.3	63.5	39.2	92.9	27.4	55.7	34.0	57.0	17.4	40.2	41.4	22.3	25.1	20.2	35.5	82.7	46.4	41.2	54.0	65.1	54.1	56.4	28.4	50.6	66.2	59.5	37.4	223.9	217.9	216.7	74.2	202.2	60.1	77.5	71.4	76.5	157.3	69.0	41.1	48.2	453.9	72.3	246.4	46.4	109.8	213.1	14.6	16.5	15.3	19.4	14.8	16.1	19.7	16.6	17.2	15.6	19.4	20.0	28.8	12.8	19.9	1.3	53.1	8.5	20.5	41.7	10.2	2.1	9.5	7.2	4.3	17.2	30.8	29.5	6.2	24.5	40.8	35.2	29.4	42.5	8.6	5.4	9.3	25.0	22.8	25.0	2.1	38.6	53.1	13.5	37.2	13.3	51.5	18.2	26.7	13.2	76.5	3.3	1.8	17.9	48.8	82.0	36.3	18.4	14.6	66.8	23.2	3.7	93.3	6.3	56.7	1.5	6.4	39.0	35.9	12.4	33.9	11.5	28.1	31.7	14.2	1.8	0.0	7.0	15.2	3.5	26.8	19.3	9.8	29.6	45.0	14.4	22.0	20.7
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"salivary gland: 72.4;stomach 1: 33.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 50.1;Cardiomyocytes: 26.2;Gastric mucus-secreting cells: 29.0;Proximal tubular cells: 25.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;Hep G2: 5.1;OE19: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	1.3	0.2	0.0	0.0	0.1	0.0	7.7	0.0	0.3	0.3	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	72.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	33.9	0.0	0.1	0.0	0.4	0.3	5.3	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.0	0.1	0.1	0.0	3.2	50.1	1.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.2	0.0	2.7	1.8	0.0	0.0	0.0	0.0	1.9	4.3	0.5	0.2	0.0	0.3	0.0	0.0	0.1	2.2	0.0	1.7	29.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.4	0.0	25.4	2.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	1.5	0.0	0.4
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619553-102711355	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.7;stomach 1: 26.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 41.3;Early spermatids: 46.5;Gastric mucus-secreting cells: 41.8;Intestinal goblet cells: 23.4;Late spermatids: 31.4;Paneth cells: 38.7;Undifferentiated cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.0;OE19: 37.3;RT4: 16.9;SK-BR-3: 14.7;T-47d: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.0	0.1	1.4	2.1	0.7	0.0	1.4	0.8	1.5	1.4	0.2	20.0	6.3	0.1	3.9	0.3	0.3	1.1	0.0	1.9	0.9	5.4	0.0	0.1	0.1	1.4	0.7	0.0	0.0	5.8	1.0	0.0	1.5	5.8	20.7	0.1	4.9	2.1	6.4	0.8	3.4	0.7	0.8	0.0	26.4	5.7	1.2	0.4	1.0	6.2	4.5	1.0	0.0	0.5	10.0	6.1	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.2	0.0	3.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	3.4	2.9	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.7	0.0	0.1	0.2	37.3	5.0	0.0	0.1	0.0	1.1	16.9	0.1	0.0	0.0	14.7	0.0	0.0	18.5	0.0	0.0	0.0	0.7	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.8	1.5	1.9	0.9	1.4	0.7	1.5	0.8	1.2	0.5	0.0	0.0	0.0	2.0	0.3	0.4	0.2	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.3	9.2	0.0	0.5	0.0	41.3	0.0	0.2	46.5	0.5	0.2	0.3	9.7	0.0	3.0	0.0	0.0	0.0	41.8	3.1	0.0	0.0	0.0	0.0	0.1	0.0	14.6	23.4	6.1	0.0	0.4	31.4	0.6	0.0	0.0	5.6	0.0	0.5	0.0	1.0	1.0	8.5	38.7	0.0	0.2	4.1	3.2	1.4	0.1	0.1	0.0	0.5	0.1	4.5	0.2	0.0	0.6	0.3	0.2	0.0	29.6	0.8
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642503-62685785	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 57.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.8;Extravillous trophoblasts: 239.4;Melanocytes: 60.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 197.2;RPTEC TERT1: 193.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.7"	"Low region specificity"	"Detected in some"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	32.4	5.6	26.2	1.8	24.0	1.3	23.4	24.2	35.7	11.1	19.6	9.8	1.2	8.7	0.3	16.7	13.1	1.8	48.6	23.9	25.4	35.8	5.0	57.2	2.4	26.5	24.8	6.5	4.9	3.8	2.9	4.7	28.0	5.9	1.8	21.5	8.5	1.0	18.8	25.6	9.2	0.8	25.7	6.6	13.5	2.1	31.6	1.1	8.6	5.6	3.2	12.0	16.8	24.9	14.8	19.1	0.8	10.8	2.5	2.1	26.5	4.7	16.6	14.1	5.4	32.0	14.9	17.8	44.2	0.5	9.6	22.0	16.4	1.0	5.4	2.1	9.6	21.7	22.1	23.8	0.1	16.6	6.7	0.0	6.5	0.3	6.2	4.2	2.5	10.7	17.1	4.6	0.0	14.8	17.2	63.9	5.4	74.1	197.2	30.6	1.1	26.2	193.9	14.2	17.4	25.1	4.1	4.4	15.7	6.5	1.0	7.5	2.8	0.4	10.5	7.0	27.2	9.2	15.9	11.1	38.1	24.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.9	0.7	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.2	26.2	24.0	24.2	35.7	23.9	25.4	26.5	24.8	28.0	25.7	31.6	24.9	61.8	3.2	1.3	1.3	13.1	27.3	1.4	19.8	1.2	14.1	1.2	0.8	4.4	1.5	5.9	25.8	31.3	2.1	3.7	7.5	0.0	5.9	0.3	8.7	3.6	40.3	0.0	2.1	7.9	2.5	239.4	4.3	20.9	35.6	0.0	0.0	14.6	0.6	5.5	0.0	6.6	8.4	2.0	9.7	33.5	0.7	0.3	11.9	60.5	3.7	0.0	6.1	0.0	1.5	0.3	11.8	1.9	0.7	19.1	3.5	0.8	9.6	1.3	43.2	0.0	1.9	2.9	0.2	3.0	1.1	16.1	23.5	5.6	0.1	7.5	11.0
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301139	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.3;Fibroblasts: 112.7;Sertoli cells: 85.5;Smooth muscle cells: 99.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 12.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 310.3;fHDF/TERT166: 116.0;RT4: 101.1;SH-SY5Y: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Cell Junctions"		"HPA051630: AB_2681557"	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	61.9	20.7	10.0	11.9	10.6	0.1	32.7	11.9	7.5	36.4	0.3	20.0	5.4	23.9	8.8	21.4	22.2	43.5	39.7	12.3	4.3	16.7	1.5	38.1	6.2	12.9	0.7	17.0	7.8	44.9	4.4	21.7	11.6	10.3	9.7	3.1	16.8	15.4	4.4	25.8	10.4	27.1	0.3	14.3	10.1	2.7	6.9	20.0	23.3	6.5	4.2	55.5	24.3	2.2	0.0	11.0	0.1	0.0	310.3	5.7	0.0	18.1	3.1	4.0	8.4	0.1	0.0	0.0	4.2	116.0	13.1	0.0	2.9	1.2	0.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.8	4.2	0.5	3.9	44.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	101.1	1.1	73.3	0.0	0.0	0.0	12.5	0.0	0.0	0.0	3.0	1.9	25.5	0.1	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	10.0	10.6	11.9	7.5	12.3	4.3	12.9	0.7	11.6	0.3	6.9	2.2	11.7	0.0	2.3	4.2	0.5	26.6	1.8	5.5	3.4	8.6	1.1	3.8	25.9	0.0	0.4	0.0	0.0	2.3	0.5	0.0	0.0	0.2	11.9	1.3	35.7	5.4	0.0	0.0	202.3	0.0	0.5	112.7	4.6	3.6	1.3	0.5	1.8	0.0	1.2	0.0	20.2	0.0	0.0	0.0	32.5	8.2	0.9	1.1	35.6	14.0	0.0	13.7	0.0	8.0	2.9	0.0	0.0	0.4	0.8	1.1	0.1	1.9	0.2	0.9	85.5	1.8	99.3	1.2	2.2	1.1	17.6	1.1	1.8	0.3	0.0	0.8
SRCIN1	"KIAA1684, p140Cap, SNIP"	ENSG00000277363	"SRC kinase signaling inhibitor 1"	Q9C0H9	17	38530031-38605952	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.3;Horizontal cells: 102.6;Inhibitory neurons: 58.5;Oligodendrocytes: 261.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009701, HPA063795"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"		"HPA009701: AB_1857324, HPA063795: AB_2685124"	"unprognostic (4.53e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.24e-4)"	"unprognostic (4.10e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.07e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-2)"	"prognostic favorable (1.76e-4)"	1.9	1.3	11.1	0.1	32.1	0.2	3.1	22.1	29.9	2.1	0.0	4.2	0.6	1.0	0.6	2.2	3.0	0.0	2.1	13.6	14.1	1.6	13.9	1.2	0.2	36.4	28.8	0.5	6.6	2.4	15.5	0.2	33.7	2.3	0.2	0.4	7.8	0.8	0.5	6.1	1.4	0.1	13.8	0.6	2.1	1.4	29.9	0.1	0.7	0.0	0.0	1.7	1.1	66.2	0.4	0.4	0.6	2.7	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.4	1.1	0.9	0.0	0.7	1.0	1.2	0.2	0.1	1.1	1.2	0.0	0.5	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.5	0.1	3.9	0.0	2.4	0.0	0.0	1.5	0.5	0.0	0.1	0.0	0.1	0.4	1.7	18.0	2.0	0.0	1.0	0.7	0.6	1.8	0.4	0.0	0.0	1.2	0.0	0.0	0.8	0.2	0.0	0.1	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	32.1	22.1	29.9	13.6	14.1	36.4	28.8	33.7	13.8	29.9	66.2	0.4	0.0	1.1	5.5	0.3	0.8	1.0	0.3	0.6	31.5	6.1	5.1	2.9	21.5	0.3	3.7	0.0	0.1	0.3	0.7	0.0	2.7	0.2	9.0	1.0	0.6	9.7	0.0	66.3	0.2	0.1	0.9	0.0	0.9	0.0	2.7	0.4	12.6	0.4	102.6	58.5	1.8	2.0	0.0	0.4	0.6	0.6	0.1	0.0	3.7	0.0	1.8	0.0	6.6	261.8	0.3	0.3	0.4	0.1	1.4	0.6	0.2	5.3	3.4	0.0	0.4	0.5	0.9	2.1	0.8	0.9	0.1	0.2	0.0	1.5	1.6
SSX2IP	hMsd1	ENSG00000117155	"SSX family member 2 interacting protein"	Q9Y2D8	1	84643706-84690803	"Predicted intracellular proteins"	"Cell adhesion, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 118.7;testis: 105.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 260.6;Early spermatids: 774.9;Late spermatids: 1095.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075946	Supported		Approved	"Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions"		"HPA075946: "	"unprognostic (5.18e-3)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.45e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.37e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.46e-2)"	1.9	3.1	8.2	5.8	13.1	14.9	5.1	12.9	23.4	6.8	4.4	8.1	43.2	9.3	22.6	6.4	7.2	8.7	9.4	13.8	3.6	16.5	14.5	3.9	6.4	1.1	1.4	2.0	7.1	9.2	9.6	6.3	1.4	12.7	7.8	118.7	6.9	11.8	3.5	6.5	26.8	10.7	0.0	5.4	7.1	105.7	1.5	12.1	8.2	2.6	6.3	5.7	3.5	11.9	39.1	19.0	15.1	27.7	5.0	15.7	18.4	65.6	33.2	28.3	22.7	13.7	8.4	38.6	11.3	55.8	36.5	21.4	27.0	21.2	39.5	7.7	23.0	36.4	22.2	11.9	10.3	32.1	2.9	6.7	34.1	31.9	20.1	18.9	9.7	14.7	76.5	14.1	18.1	15.0	22.5	12.7	22.3	7.4	29.6	15.1	66.0	17.0	29.5	22.3	29.4	36.7	18.4	29.6	32.9	9.5	17.2	16.4	2.9	26.8	39.2	36.9	65.9	14.7	18.7	42.0	22.4	28.2	16.9	0.8	0.8	3.9	8.2	1.9	4.5	1.2	2.6	3.3	3.5	1.2	3.3	5.1	1.1	4.6	2.6	4.5	1.5	3.9	8.2	13.1	12.9	23.4	13.8	3.6	1.1	1.4	1.4	0.0	1.5	11.9	4.4	3.2	3.0	38.2	3.7	10.5	8.6	8.7	12.5	45.6	10.5	7.0	36.8	21.5	7.3	11.0	260.6	5.3	23.9	3.9	7.9	7.3	774.9	14.9	8.9	5.0	8.4	46.7	108.5	12.0	1.9	15.7	5.6	11.6	4.5	4.2	3.6	14.9	2.7	20.2	70.2	9.3	2.0	1.9	5.6	1095.3	15.8	24.1	5.4	18.7	3.5	187.4	15.5	16.6	23.9	9.4	4.6	11.3	12.7	4.3	19.7	44.9	13.3	158.0	0.0	4.2	7.3	71.7	53.6	13.6	9.8	0.5	8.4	2.0	10.7	4.2
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968915	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 893.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	37.4	16.5	22.1	4.4	35.3	1.1	30.8	21.4	24.4	33.2	17.9	30.5	7.1	42.3	16.5	60.4	27.8	12.6	37.1	22.0	22.2	24.3	18.6	34.0	5.7	26.6	28.6	22.3	30.0	13.4	16.8	31.6	25.2	20.4	9.5	10.0	29.6	10.9	22.0	27.8	19.8	17.4	20.6	13.5	25.8	29.7	30.3	3.7	24.8	5.0	10.2	23.8	35.3	42.6	62.4	36.8	29.1	18.4	17.0	31.7	28.9	18.6	21.1	18.0	20.2	59.2	22.9	0.3	24.8	24.6	21.3	47.4	20.1	23.8	19.0	0.5	14.9	0.3	22.3	24.7	57.9	0.1	0.8	16.5	15.8	21.4	39.2	23.0	38.2	0.1	24.3	12.5	14.2	32.2	0.2	0.7	21.9	23.4	14.6	0.1	35.0	0.2	28.1	33.4	12.9	16.8	39.2	12.8	16.8	42.9	13.3	0.6	54.7	14.3	23.9	12.5	25.6	4.4	4.6	0.4	17.8	0.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	35.3	21.4	24.4	22.0	22.2	26.6	28.6	25.2	20.6	30.3	42.6	212.1	169.9	49.2	299.7	1.6	35.8	115.2	36.4	39.3	42.4	53.7	28.6	107.2	51.5	48.6	58.8	10.4	32.3	0.8	87.7	25.4	116.0	19.1	132.2	97.0	166.0	46.0	2.7	293.8	83.7	11.3	56.6	86.6	290.7	5.7	87.7	100.3	49.1	3.8	126.2	187.3	45.4	32.6	6.1	12.1	13.7	33.8	5.2	64.0	266.1	1.6	32.8	0.0	345.3	893.8	178.3	82.0	63.9	5.9	151.4	37.8	26.0	39.2	52.4	78.9	64.1	118.7	63.0	83.9	139.2	60.1	33.7	4.1	120.8	33.1	194.6
TMEM186	"C16orf51, DKFZP564K2062"	ENSG00000184857	"Transmembrane protein 186"	Q96B77	16	8780384-8797642	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.8;Late spermatids: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018226, HPA063559"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Cell Junctions"		"HPA018226: AB_1845579, HPA063559: AB_2685041"	"unprognostic (3.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.93e-8)"	"unprognostic (1.06e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.89e-2)"	7.0	11.2	8.6	6.2	9.0	2.2	10.0	8.8	10.5	6.5	9.2	10.8	9.6	7.5	12.5	9.6	9.3	4.6	13.2	8.5	8.9	12.3	16.3	5.8	8.6	8.6	8.7	8.5	8.9	12.4	9.5	7.2	8.8	7.5	11.2	5.0	8.3	7.2	18.5	8.3	9.7	7.5	8.6	9.9	9.5	7.8	8.9	7.9	7.6	21.3	10.7	7.5	6.5	9.2	10.4	16.1	11.8	15.1	19.8	10.5	11.2	11.8	12.1	15.2	12.5	15.9	17.1	31.9	9.8	8.7	10.4	19.8	21.2	16.8	17.3	18.7	20.4	13.4	22.3	34.1	22.0	15.1	10.3	12.7	27.8	16.7	24.4	12.5	14.0	25.9	23.3	17.1	9.0	28.3	11.7	14.7	15.0	22.0	13.9	24.4	15.5	35.3	16.3	8.8	18.1	17.3	16.2	22.7	14.3	12.0	27.1	12.0	8.9	10.8	15.1	27.0	9.9	15.6	17.6	15.5	16.8	27.1	8.8	9.9	8.7	6.8	7.5	8.6	10.0	13.1	8.1	8.8	9.1	11.5	13.7	10.9	4.1	9.1	13.3	7.0	11.7	7.4	8.6	9.0	8.8	10.5	8.5	8.9	8.6	8.7	8.8	8.6	8.9	9.2	3.4	6.4	6.7	2.6	6.7	8.2	7.1	16.1	5.7	6.9	7.3	6.6	2.7	10.0	13.1	11.0	0.0	23.4	4.4	7.8	21.5	15.1	44.8	4.8	6.0	5.6	13.8	8.2	1.9	11.2	13.3	5.7	6.1	5.0	7.0	9.6	6.1	12.8	13.2	13.5	1.5	9.4	12.2	4.9	4.7	106.9	9.3	2.5	7.2	1.0	9.9	10.8	11.3	1.5	1.9	9.9	6.7	6.4	5.1	9.8	14.8	21.9	9.3	5.6	13.1	6.6	5.3	21.3	11.9	9.5	9.5	15.1	5.0	11.0	16.0	5.8
TNK1	KOS1	ENSG00000174292	"Tyrosine kinase non receptor 1"	Q13470	17	7380534-7389774	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 13.1;Distal enterocytes: 13.9;Gastric mucus-secreting cells: 16.8;Proximal enterocytes: 11.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.9"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HaCaT: 9.1;HBEC3-KT: 6.0;hTCEpi: 6.6;T-47d: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012065, HPA056452"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 35: Glandular cells - Unknown function"	"Cell Junctions"		"HPA012065: AB_1858165, HPA056452: "	"unprognostic (4.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.77e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.52e-4)"	3.6	0.9	0.3	1.2	0.5	0.2	5.6	1.9	0.4	3.8	0.4	7.3	3.7	2.4	0.8	7.1	3.1	1.0	1.6	0.2	0.3	5.2	5.1	2.6	1.5	0.0	0.0	3.3	7.8	3.0	3.0	0.2	0.0	7.0	2.3	1.3	8.1	1.4	0.5	8.8	7.7	0.5	0.0	3.1	7.6	1.9	0.2	0.5	4.8	0.1	1.7	4.2	5.6	0.3	5.7	0.9	0.1	0.4	0.0	0.0	3.7	0.2	0.0	0.3	0.4	2.9	2.6	0.0	2.2	0.3	0.1	9.1	0.0	6.0	0.1	0.6	1.3	0.0	3.5	1.6	0.3	0.0	0.2	0.1	6.6	0.0	1.0	0.1	0.0	2.4	0.7	0.0	0.0	4.4	0.6	0.0	0.7	4.9	0.7	0.2	0.1	0.6	4.1	2.6	0.1	0.4	3.1	4.5	0.8	0.2	7.4	0.1	1.5	0.2	0.7	0.2	0.0	0.4	0.9	0.1	0.1	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.6	0.5	0.6	0.4	0.0	0.4	1.1	1.3	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.5	1.9	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	2.6	6.4	3.4	0.0	2.9	2.5	2.6	5.1	13.1	1.8	9.1	7.4	1.1	2.8	3.5	1.8	0.0	0.2	0.3	13.9	0.0	5.2	1.5	2.8	1.0	1.5	3.0	0.4	0.5	6.9	0.6	1.0	16.8	4.6	0.0	0.1	1.1	2.9	0.1	0.0	0.4	7.0	2.0	0.0	0.5	1.5	1.2	0.4	0.0	0.0	0.4	0.2	2.1	0.0	0.1	8.5	8.0	0.4	0.4	3.9	11.6	1.6	1.9	2.9	0.0	0.8	1.8	1.5	0.6	11.0	2.4	0.7	2.4	0.1	7.2	2.2
TSSK4	"C14orf20, STK22E"	ENSG00000139908	"Testis specific serine kinase 4"	Q6SA08	14	24205696-24208362	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 38.1"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 253.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060660, HPA077103"	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Cell Junctions"		"HPA060660: AB_2684339, HPA077103: AB_2732332"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-3)"	"unprognostic (3.42e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (8.98e-2)"	"unprognostic (7.26e-2)"	1.0	1.1	0.7	2.0	0.4	3.4	1.0	1.0	0.3	1.4	0.0	1.4	1.6	1.1	0.3	1.3	1.2	1.6	0.7	0.6	0.1	0.8	0.6	1.0	2.7	0.3	0.3	1.1	1.5	0.0	0.9	0.4	0.3	0.9	0.0	3.1	1.5	0.0	1.3	4.2	1.7	0.0	0.2	1.7	1.2	38.1	0.3	0.0	1.4	0.0	0.0	1.1	1.1	0.3	0.6	2.3	2.2	0.8	0.0	0.0	2.4	0.9	0.0	0.0	0.0	1.3	2.2	1.8	0.5	0.1	0.4	2.1	0.0	0.1	0.0	0.9	1.7	2.0	3.4	1.7	0.0	1.0	2.1	0.0	0.0	0.0	0.3	1.9	0.0	2.1	0.8	1.2	0.0	2.2	2.1	1.1	0.4	0.5	1.8	1.8	0.8	1.5	0.0	3.0	1.2	1.2	1.7	1.4	0.4	0.9	1.0	1.0	0.9	1.6	1.0	2.1	0.7	2.3	3.0	2.6	0.5	1.6	0.5	0.0	0.2	0.4	0.4	0.2	0.1	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.5	0.1	0.3	0.1	0.1	0.7	0.4	1.0	0.3	0.6	0.1	0.3	0.3	0.3	0.2	0.3	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	253.7	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	26.5	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.3	0.1	0.8	0.0	0.0	0.2	0.1	6.8	0.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 389.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 142.6;Hepatic stellate cells: 94.9;Kupffer cells: 561.9;Proximal tubular cells: 188.4;Theca cells: 186.8"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 89.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 164.7;HSkMC: 111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Approved	"Cell Junctions"		NA	NA	624000000	1300000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Cell Junctions"		"CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215"	"unprognostic (2.96e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.19e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.55e-2)"	29.1	43.2	4.0	34.7	3.5	8.3	15.0	5.0	4.5	6.7	6.0	15.0	15.4	9.4	2.4	7.7	9.8	29.5	9.4	2.8	7.6	64.3	43.7	18.1	96.3	6.5	6.2	39.5	13.3	18.4	7.0	43.2	7.0	9.7	23.5	1.5	8.7	5.5	3.1	3.6	14.4	11.0	6.0	389.3	14.4	5.4	11.2	24.6	7.3	6.3	75.9	72.7	5.5	5.9	0.0	0.0	0.8	0.3	0.6	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.1	25.7	0.0	0.0	0.0	0.0	164.7	0.2	0.0	111.0	0.0	29.3	0.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.5	5.0	4.5	2.8	7.6	6.5	6.2	7.0	6.0	11.2	5.9	9.6	0.0	5.6	0.0	1.7	9.9	0.5	0.4	0.0	0.1	0.9	0.6	1.9	0.0	0.2	3.7	0.0	1.3	1.1	0.0	9.8	142.6	0.3	0.7	14.0	40.3	0.0	2.7	0.0	3.2	1.2	60.1	0.0	0.8	1.3	7.5	94.9	3.2	3.6	0.0	0.0	0.0	0.0	561.9	15.9	0.0	17.1	7.9	1.8	6.5	0.0	4.0	0.0	0.0	0.1	2.3	1.1	7.5	0.9	1.3	0.0	188.4	1.5	0.0	0.0	5.5	19.2	0.1	2.3	0.4	7.4	2.7	10.0	186.8	0.1	0.4
VPS13B	"CHS1, COH1"	ENSG00000132549	"Vacuolar protein sorting 13 homolog B"	Q7Z7G8	8	99013266-99877580	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 160.9;Excitatory neurons: 235.2;Inhibitory neurons: 253.2;Microglial cells: 204.2;Oligodendrocyte precursor cells: 217.1;Oligodendrocytes: 238.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043865			Approved	"Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"		"HPA043865: AB_2678704"	"unprognostic (4.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.65e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.90e-1)"	4.0	3.0	2.4	4.4	3.3	13.4	4.7	4.5	3.0	5.4	8.2	3.6	2.3	7.2	3.8	4.4	4.9	4.4	2.3	2.0	1.9	3.8	3.1	3.5	4.8	3.6	2.4	8.1	3.4	6.8	2.3	4.0	3.6	4.9	3.7	6.0	3.2	4.1	2.9	4.0	3.0	5.4	2.2	4.2	3.6	4.9	4.9	7.1	4.7	4.4	5.0	4.5	3.7	5.3	8.6	6.1	7.2	5.3	13.3	15.9	3.6	5.4	9.9	5.3	7.0	3.6	4.3	4.8	6.9	9.3	3.9	3.9	5.0	5.0	9.6	7.7	4.6	10.3	6.5	2.8	4.3	5.0	7.4	10.3	4.6	8.5	12.2	7.4	7.6	7.9	7.9	12.4	6.1	5.3	10.5	2.9	2.3	8.9	2.2	8.3	5.1	9.1	3.5	8.0	2.1	6.0	8.4	4.0	4.0	6.4	7.2	5.6	10.8	7.9	7.4	7.1	4.6	5.0	6.2	12.7	6.0	7.9	5.6	3.0	1.2	2.8	1.2	1.0	1.1	3.3	1.0	0.9	0.5	1.6	1.7	1.1	6.1	0.7	2.3	0.6	1.4	0.5	2.4	3.3	4.5	3.0	2.0	1.9	3.6	2.4	3.6	2.2	4.9	5.3	15.5	19.2	12.2	160.9	24.2	8.8	7.6	9.2	15.4	15.1	8.9	7.6	12.8	10.0	11.9	3.7	37.5	4.9	21.6	7.3	0.0	4.9	8.6	10.9	42.7	11.5	9.0	22.9	235.2	4.6	4.0	18.2	28.1	12.7	3.8	10.4	6.4	5.2	6.5	11.8	253.2	11.9	8.2	15.6	11.3	9.6	27.7	17.8	7.2	204.2	15.0	9.4	17.5	217.1	238.1	4.0	11.0	20.7	19.2	6.2	9.8	2.9	8.2	12.9	0.0	15.7	14.7	23.9	7.3	13.0	9.7	4.2	19.5	14.6	7.4	5.7
WDPCP	"BBS15, C2orf86, CPLANE5, fritz, hFrtz"	ENSG00000143951	"WD repeat containing planar cell polarity effector"	O95876	2	63119559-63827843	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 18.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 169.9;Alveolar cells type 2: 128.0;Astrocytes: 124.7;Excitatory neurons: 261.4;Inhibitory neurons: 240.9;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 296.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044144	Uncertain		Approved	"Cell Junctions"		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 6: Brain - Smell perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"		"HPA044144: AB_10969458"	"unprognostic (3.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.22e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-1)"	4.7	3.5	11.3	2.5	11.7	8.2	3.2	17.7	15.7	2.5	6.5	1.6	1.8	3.9	4.0	2.0	4.2	2.8	4.9	10.4	6.9	3.6	2.4	2.5	3.3	6.4	5.4	4.6	1.5	2.9	1.9	2.6	8.4	2.6	1.8	12.2	2.2	2.1	5.3	3.4	1.7	3.0	3.2	3.3	3.3	5.1	6.3	3.6	3.5	2.9	2.7	1.8	1.1	18.6	5.2	4.6	3.3	4.0	3.7	4.6	3.0	4.3	2.2	2.8	2.3	3.3	2.6	5.8	3.5	2.9	3.3	3.4	2.3	2.8	3.3	5.7	3.8	6.1	3.5	2.8	2.5	5.0	4.1	2.3	1.9	2.9	1.9	3.7	2.9	6.7	2.3	5.7	2.9	5.3	5.8	5.1	3.9	2.7	1.7	6.2	4.3	5.0	1.9	2.5	5.2	5.2	3.7	4.4	5.3	4.7	3.8	3.9	4.7	4.6	7.2	4.0	3.6	5.3	3.6	10.3	5.2	5.3	5.3	6.6	2.8	1.5	1.9	1.5	3.7	1.8	1.7	2.6	2.3	3.1	2.3	3.6	1.9	3.8	1.3	2.7	1.5	1.1	11.3	11.7	17.7	15.7	10.4	6.9	6.4	5.4	8.4	3.2	6.3	18.6	6.0	169.9	128.0	124.7	8.0	4.1	3.2	4.3	2.8	16.1	4.4	3.2	10.1	7.2	59.6	1.8	22.9	2.5	5.5	0.8	1.9	2.6	46.7	17.9	6.2	14.4	0.0	7.8	261.4	2.2	2.6	13.5	6.6	3.7	65.0	7.4	5.0	1.8	4.0	11.8	240.9	1.3	4.1	3.0	4.4	17.5	4.4	8.4	5.4	103.0	3.8	7.5	6.2	136.2	296.3	1.8	1.6	3.8	5.1	1.5	0.5	4.5	98.8	27.4	0.0	8.6	5.7	16.1	9.5	2.3	3.4	1.9	9.4	4.0	1.1	1.7